Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
21491868	s-kryog	— (—)	1492	1673	100.00%	Distribution not available
21491868	s-kryog	g/l (g/l)	181	269	39.78%
21491868	s-kryopre	— (—)	30	41	100.00%	Distribution not available
21491868	s-kryopre	g/l (g/l)	8	8	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other disorders of skin and subcutaneous tissue

559

831

5.74

281.34

1.3

1.2

0.74

0.28

g/l

1.07

ILD medications: immunosuppressive drugs

468

713

6.00

253.80

1.3

1.1

0.58

0.38

g/l

0.38

Ulcer of lower limb, not elsewhere classified

217

150

14.91

242.90

1.3

1.2

0.44

0.13

g/l

—

Systemic connective tissue disorders

343

491

7.10

226.60

1.2

0.69

0.29

g/l

0.65

ILD medications

632

765

4.48

202.67

1.3

1.1

0.42

0.37

g/l

0.09

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

594

943

4.27

197.80

1.3

1.1

0.51

0.46

g/l

0.07

ILD medications: prednisolone, methylprednisolone, prednisone

595

760

4.38

188.50

1.3

1.1

0.46

0.37

g/l

0.15

Oral corticosteroids

589

880

3.95

168.36

1.3

1.2

0.58

0.35

g/l

0.47

Inflammatory bowel disease treatment related agents

601

897

3.74

156.56

1.3

1.2

0.47

0.35

g/l

0.22

Other and unspecified dermatitis

371

817

4.58

154.41

1.3

1.2

0.49

0.54

g/l

0.06

First line medication for Crohn's disease

560

785

3.86

150.28

1.3

1.1

0.31

0.35

g/l

0.08

Other systemic involvement of connective tissue (FG)

225

326

6.87

143.47

1.2

0.30

0.19

g/l

0.44

Dermatitis

397

956

4.09

141.91

1.3

1.2

0.49

0.53

g/l

0.06

Other systemic involvement of connective tissue

234

371

6.40

140.43

1.2

0.31

0.30

g/l

0.02

Autoimmune diseases excluding thyroid diseases

537

790

3.70

137.11

1.3

1.2

0.52

0.40

g/l

0.20

Coagulation defects, purpura and other haemorrhagic conditions

204

288

7.22

136.73

1.5

1.2

0.69

0.25

g/l

0.62

Autoimmune diseases excluding thyroid diseases, strict definition

516

761

3.71

132.16

1.3

1.2

0.48

0.41

g/l

0.11

All chronic kidney diseases

337

588

4.61

130.94

1.4

1.2

0.36

0.59

g/l

0.38

Renal failure

309

549

4.84

130.16

1.4

1.2

0.36

0.69

g/l

0.49

Fever of other and unknown origin

332

644

4.50

129.12

1.3

1.2

0.60

0.44

g/l

0.23

Autoimmune diseases related-to ILD

463

1125

3.46

124.34

1.2

0.40

0.51

g/l

0.19

Second line medication for Crohn's disease

359

944

3.83

117.81

1.3

1.2

0.57

0.29

g/l

0.64

L04AX Other immunosuppressants

353

918

3.87

117.79

1.3

1.2

0.57

0.30

g/l

0.59

Chronic kidney disease

222

383

5.64

115.72

1.4

1.2

0.40

0.61

g/l

0.23

Purpura and other haemorrhagic conditions

154

194

8.11

114.12

1.5

1.2

0.72

0.26

g/l

0.61

Diseases of the skin and subcutaneous tissue

409

533

3.87

107.23

1.2

0.21

0.43

g/l

0.54

Other bacterial diseases, including avohilmo

489

972

3.15

104.30

1.2

0.57

0.43

g/l

0.20

Bacterial infection, other or unspecified, including avohilmo

317

661

3.95

102.77

1.2

1.3

0.52

0.60

g/l

0.10

Diseases of arteries, arterioles and capillaries

366

739

3.66

102.62

1.2

0.42

0.62

g/l

0.29

Glomerular diseases

167

261

6.51

101.84

1.5

1.2

0.25

0.19

g/l

0.26

Other bacterial diseases

461

965

3.18

101.49

1.2

0.38

0.54

g/l

0.30

Bacterial infection, other or unspecified

293

612

4.07

99.52

1.2

1.3

0.45

0.67

g/l

0.32

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

15.35

95.13

1.5

1.3

1.42

0.07

g/l

—

Liquid cancers

205

404

4.85

89.98

1.4

1.1

1.31

0.13

g/l

2.33

Anaemias

145

110

8.52

89.95

1.3

1.1

0.11

0.19

g/l

—

All kidney diseases

460

1052

2.94

89.51

1.3

1.2

0.39

0.56

g/l

0.32

Autoimmune diseases

469

793

3.01

86.65

1.2

0.37

0.40

g/l

0.04

Primary_lymphoid and hematopoietic malignant neoplasms

174

332

5.31

86.14

1.5

1.1

1.37

0.15

g/l

2.30

Dermatitis and eczema

507

1084

2.78

86.00

1.2

0.48

0.50

g/l

0.03

General symptoms and signs

452

746

3.05

84.63

1.3

1.2

0.21

0.42

g/l

0.59

Tramadol

375

706

3.21

81.30

1.2

0.73

0.41

g/l

0.49

Bacterial Sepsis

254

559

3.78

77.79

1.2

0.24

0.68

g/l

0.91

Finngen Rheumatological endpoints

419

816

2.93

76.78

1.2

0.22

0.36

g/l

0.43

Reimbursement for rheumatic diseases

302

935

3.23

76.60

1.2

0.45

g/l

0.00

Oedema, not elsewhere classified

182

388

4.62

76.28

1.4

1.2

1.06

0.37

g/l

—

Other and unspecified polyneuropathies, also in other diseases

148

273

5.50

76.15

1.5

1.2

0.51

0.16

g/l

0.92

Used for control exclusion in common control thyroid runs

421

725

2.94

74.60

1.2

0.24

0.42

g/l

0.40

Aplastic and other anaemias

247

623

3.65

74.20

1.4

1.2

0.68

0.22

g/l

1.00

Polyneuropathies and other disorders of the peripheral nervous system

157

313

5.08

74.03

1.5

1.2

0.46

0.15

g/l

1.02

Septicaemia

211

475

4.08

73.87

1.2

0.16

0.56

g/l

1.16

Renal tubulo-interstitial diseases

394

1039

2.79

71.76

1.4

1.2

0.44

0.56

g/l

0.21

Liquid cancers, including Hilmo

211

468

4.01

71.36

1.4

1.2

1.31

0.15

g/l

2.29

Acute renal failure

147

287

5.18

70.98

1.4

1.2

0.19

0.41

g/l

—

Other specified/unspecified systemic involvement of connective tissue

11.03

70.75

1.2

1.3

0.19

0.38

g/l

—

Heart failure, not strict

332

729

3.08

69.86

1.3

1.2

0.15

0.76

g/l

1.81

Explicit Sepsis, including avohilmo

231

577

3.65

69.27

1.2

0.16

0.68

g/l

1.39

Dialysis, with operation codes

110

168

6.66

68.70

1.6

1.2

0.28

0.30

g/l

0.04

Other septicaemia, including avohilmo

192

441

4.11

68.68

1.3

1.2

0.18

0.56

g/l

1.07

Glomerulonephritis

100

138

7.40

68.62

1.7

1.2

0.35

0.10

g/l

—

Other septicaemia

188

429

4.16

68.36

1.3

1.2

0.18

0.53

g/l

0.92

Implicit bacterial Sepsis

219

499

3.79

68.08

1.2

0.26

0.71

g/l

0.84

Other and unspecified anaemias

225

583

3.65

67.99

1.3

1.2

0.64

0.22

g/l

0.70

Cardiovascular diseases

255

356

3.82

67.63

1.2

0.10

0.20

g/l

—

Other anaemias

226

588

3.62

67.53

1.3

1.2

0.64

0.22

g/l

0.70

Nephropathy related operations

109

171

6.49

66.37

1.6

1.2

0.43

0.31

g/l

—

Erysipelas, including avohilmo

318

790

2.99

65.97

1.2

0.72

0.51

g/l

0.18

Glomerular disorders in diseases classified elsewhere

103

154

6.81

65.66

1.2

0.12

0.14

g/l

—

Explicit Sepsis

224

574

3.58

65.26

1.2

0.16

0.55

g/l

1.16

Implicit bacterial Sepsis, including avohilmo

231

544

3.55

64.95

1.2

0.58

0.52

g/l

0.05

Polyarthropathies

320

682

3.03

64.75

1.2

0.38

0.47

g/l

0.18

Other soft tissue disorders, not elsewhere classified

406

862

2.69

64.21

1.2

0.61

0.44

g/l

0.18

Erysipelas

253

665

3.30

64.11

1.2

0.50

0.63

g/l

—

Pain in limb

366

850

2.75

62.32

1.2

0.82

0.45

g/l

0.42

Cerebrovascular diseases (FINNGEN)

166

254

4.61

61.93

1.1

1.2

0.13

0.28

g/l

—

L04AA Selective immunosuppressants

150

351

4.32

58.22

1.3

1.2

0.18

0.23

g/l

0.24

Chronic ulcer of skin, not elsewhere classified

9.51

57.25

1.2

1.04

0.13

g/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

163

6.02

55.13

1.2

1.1

0.75

0.11

g/l

—

Opioids

381

762

2.59

54.58

1.2

0.21

0.40

g/l

0.56

Certain infectious and parasitic diseases

361

680

2.67

54.11

1.2

1.1

0.15

0.38

g/l

0.70

Urticaria and erythema

195

589

3.33

52.33

1.3

1.2

0.93

0.18

g/l

0.96

Other arthritis (FG)

157

413

3.83

51.95

1.3

1.2

0.53

0.39

g/l

—

Cardiovascular diseases (excluding rheumatic etc)

260

494

3.02

50.70

1.2

0.12

0.34

g/l

1.21

Certain disorders involving the immune mechanism

121

277

4.42

48.40

1.8

1.2

0.71

0.12

g/l

1.07

Diseases of arteries, arterioles and capillaries (FINNGEN)

127

188

4.69

48.14

1.2

0.44

0.29

g/l

0.15

Headache

256

712

2.79

47.53

1.2

1.11

0.42

g/l

0.79

Implicit Sepsis

302

876

2.55

46.56

1.3

1.2

0.25

0.68

g/l

1.21

Abnormal findings on examination of blood, without diagnosis

212

648

2.98

46.04

1.5

1.2

1.34

0.28

g/l

1.24

Implicit Sepsis, including avohilmo

320

943

2.43

44.45

1.3

1.2

0.47

0.59

g/l

0.16

Symptoms and signs involving the skin and subcutaneous tissue

306

1203

2.41

44.40

1.3

1.2

0.64

0.47

g/l

0.16

Heart failure,strict

215

501

3.01

44.39

1.3

1.2

0.25

0.84

g/l

1.16

Pain in joint

237

503

2.90

44.38

1.2

0.73

0.21

g/l

0.57

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

105

6.69

43.35

1.4

1.3

1.66

0.34

g/l

—

Codeine

337

754

2.42

43.00

1.2

0.22

0.40

g/l

0.57

Any gastric operation

274

507

2.72

42.72

1.2

0.13

0.26

g/l

0.92

GASTRO-related operations

274

507

2.72

42.72

1.2

0.13

0.26

g/l

0.92

Persons encountering health services in other circumstances, wide

420

996

2.17

41.43

1.3

1.2

0.35

0.43

g/l

0.18

Malaise and fatigue

198

528

2.96

41.30

1.3

1.2

0.59

0.48

g/l

—

Extracorporeal dialysis

7.17

40.74

1.7

1.2

0.09

0.12

g/l

—

Other specified/unspecified arthritis

139

398

3.52

40.71

1.3

1.2

0.61

0.54

g/l

—

Hypertensive diseases (excluding secondary)

206

400

3.01

40.23

1.2

0.11

0.36

g/l

1.15

341

866

2.31

40.15

1.2

0.39

0.60

g/l

0.36

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

341

866

2.31

40.15

1.2

0.39

0.60

g/l

0.36

Pain, not elsewhere classified

128

352

3.66

39.83

1.2

0.86

0.19

g/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

403

995

2.16

39.47

1.3

1.2

0.42

0.43

g/l

0.02

Urticaria

153

475

3.24

39.43

1.3

1.2

1.09

0.16

g/l

1.04

Condition for Implicit Sepsis (Organ dysfunction codes)

318

959

2.30

39.00

1.3

1.2

0.42

0.59

g/l

0.27

L04AD Calcineurin inhibitors

167

5.04

38.95

1.4

1.2

0.05

0.14

g/l

—

Heart failure and antihypertensive medication

114

171

4.36

38.84

1.3

1.2

0.14

0.37

g/l

0.50

Other heart diseases

185

394

3.06

38.65

1.2

0.13

0.25

g/l

0.72

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

363

1052

2.19

38.51

1.2

0.22

0.56

g/l

1.29

Viral hepatitis, including avohilmo

124

5.74

37.84

1.6

1.1

0.33

0.06

g/l

—

Pneumonias (Asthma/COPD co-morbidities)

377

1163

2.12

37.47

1.3

1.2

0.40

0.55

g/l

0.29

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

331

1006

2.23

37.31

1.2

0.44

0.59

g/l

0.22

All pneumoniae

379

1167

2.11

37.30

1.3

1.2

0.40

0.55

g/l

0.30

Pneumonia, organism unspecified

345

1086

2.18

37.26

1.3

1.2

0.42

0.56

g/l

0.26

Other disorders of veins

188

670

2.78

36.79

1.1

1.2

0.51

0.41

g/l

0.09

Influenza and pneumonia

390

1157

2.08

36.54

1.2

0.40

0.55

g/l

0.29

Viral hepatitis

118

5.78

36.45

1.6

1.1

0.33

0.06

g/l

—

Other and unspecified urticaria

109

286

3.84

36.39

1.4

1.2

1.74

0.14

g/l

—

Heart failure, strict

225

600

2.62

36.16

1.3

1.2

0.25

0.76

g/l

1.08

Certain infectious and parasitic diseases, including avohilmo

234

439

2.68

35.61

1.2

1.1

0.27

0.15

g/l

0.53

Implicit viral Sepsis, including avohilmo

138

430

3.22

35.26

1.3

1.2

0.69

0.36

g/l

0.33

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

367

1173

2.09

35.21

1.3

1.2

0.41

0.55

g/l

0.27

Exposure to unspecified factor

380

1261

2.05

35.11

1.2

0.51

0.47

g/l

0.04

Other diseases of blood and blood-forming organs, wide

119

343

3.50

34.61

1.2

0.26

0.22

g/l

—

Asthma, excluding more controls

261

543

2.47

34.40

1.2

1.54

0.39

g/l

—

Peripheral artery disease

166

449

2.93

34.15

1.2

0.58

0.66

g/l

0.06

Other specific joint derangements/joint disorders

277

744

2.33

33.92

1.2

0.28

0.46

g/l

0.43

STROKE

218

572

2.57

33.71

1.1

1.2

0.23

0.77

g/l

1.30

Examination and observation for other reasons

222

480

2.62

33.68

1.3

1.2

0.35

0.22

g/l

0.32

Codeine or tramadol medication

405

1098

2.01

33.33

1.2

0.48

0.43

g/l

0.06

Neurological diseases, wide definition

4.93

32.89

1.2

1.3

0.06

0.62

g/l

—

Unspecified kidney failure

116

5.49

32.65

1.5

1.2

0.11

0.33

g/l

—

Disturbances of skin sensation

135

442

3.07

31.94

1.5

1.2

1.05

0.20

g/l

—

Covid-19 confirmed case

156

554

2.83

31.79

1.2

0.68

0.26

g/l

—

Asthma

268

591

2.34

31.67

1.2

1.54

0.38

g/l

—

Infections of the skin and subcutaneous tissue

241

1039

2.29

31.59

1.2

0.16

0.43

g/l

1.25

Diseases of the musculoskeletal system and connective tissue

177

304

2.93

31.58

1.2

1.3

0.09

0.63

g/l

—

All-cause Heart Failure

212

593

2.50

31.10

1.3

1.2

0.26

0.76

g/l

1.04

Oxycodone

150

443

2.91

31.07

1.5

1.1

0.93

0.50

g/l

0.35

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

165

362

2.88

30.94

1.2

0.11

0.38

g/l

1.08

Atherosclerosis, excluding cerebral and coronary sclerosis

154

420

2.89

30.93

1.2

0.50

0.52

g/l

0.01

Enlarged lymph nodes

183

4.29

30.35

1.5

1.2

1.10

0.12

g/l

1.16

Soft tissue disorders

348

869

2.06

30.07

1.2

0.25

0.44

g/l

0.56

Asthma (mode)

261

596

2.31

29.94

1.2

1.00

0.38

g/l

—

Provisional assignment of new diseases of uncertain etiology

215

913

2.34

29.81

1.3

1.2

0.71

0.33

g/l

0.43

Complications of surgical and medical care, not elsewhere classified

356

1205

1.97

29.54

1.3

1.2

0.58

0.46

g/l

0.18

Codes for special purposes

215

917

2.33

29.51

1.3

1.2

0.71

0.33

g/l

0.43

Osteopathies and chondropathies

223

887

2.31

29.33

1.3

1.2

1.01

0.34

g/l

0.63

Hypertension

280

722

2.19

29.21

1.2

0.14

0.47

g/l

1.45

Non-Hodgkin lymphoma, all, including Hilmo

164

4.43

29.14

1.7

1.2

1.19

0.09

g/l

1.48

Hypertensive diseases

280

723

2.19

29.13

1.2

0.14

0.47

g/l

1.45

Hypertension, essential

274

704

2.21

29.01

1.3

1.2

0.15

0.49

g/l

1.35

Asthma (only as main-diagnosis), excluding more controls

231

543

2.36

28.29

1.1

1.2

1.05

0.39

g/l

—

Dyspnoea

322

1164

2.00

28.23

1.3

1.2

0.41

0.54

g/l

0.27

Asthma, unspecified (mode), excluding more controls

182

515

2.54

27.89

1.3

1.2

1.15

0.42

g/l

—

Cerebrovascular diseases

266

862

2.15

27.77

1.1

1.2

0.15

0.59

g/l

1.99

Other heart diseases, wide

319

959

2.02

27.48

1.2

0.21

0.59

g/l

1.16

Venous thromboembolism

204

851

2.32

27.45

1.3

1.2

0.50

0.55

g/l

—

Antihypertensive medication - note that there are other indications

210

450

2.44

27.31

1.2

0.13

0.36

g/l

—

Asthma (only as main-diagnosis)

240

591

2.28

27.29

1.1

1.2

1.06

0.38

g/l

—

Rheumatoid arthritis

131

404

2.88

27.05

1.1

1.2

0.22

0.54

g/l

—

Heart failure and bmi 25plus

132

296

2.99

26.82

1.3

1.2

0.16

1.00

g/l

—

Persons encountering health services for specific procedures and health care

370

1153

1.90

26.65

1.3

1.2

0.34

0.55

g/l

0.50

Gout

112

308

3.14

26.52

1.2

0.75

0.46

g/l

0.22

Asthma, unspecified (mode)

188

562

2.42

26.24

1.3

1.2

1.15

0.41

g/l

—

Complications of procedures, not elsewhere classified

291

1173

2.00

26.22

1.3

1.2

0.40

0.47

g/l

0.13

Diseases of liver

146

557

2.63

26.10

1.1

1.2

0.29

0.18

g/l

—

Dental caries

115

364

3.00

25.81

1.3

1.2

0.15

0.27

g/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

241

997

2.11

25.34

1.4

1.2

0.48

0.51

g/l

0.04

Bleeding

287

1007

2.00

25.15

1.2

0.81

0.40

g/l

0.51

Metabolic disorders

324

1004

1.94

25.04

1.3

1.2

0.20

0.35

g/l

0.59

Abnormalities of breathing

300

861

2.00

24.87

1.2

0.44

0.51

g/l

0.10

Implicit viral Sepsis

294

3.25

24.82

1.3

1.2

0.09

0.39

g/l

—

Viral Sepsis

294

3.25

24.82

1.3

1.2

0.09

0.39

g/l

—

Low back pain

272

905

2.03

24.64

1.3

1.2

0.51

0.54

g/l

0.04

Dorsalgia

332

914

1.93

24.46

1.2

0.49

0.54

g/l

0.06

Caries of dentine

103

328

3.04

23.92

1.3

1.2

0.15

0.25

g/l

—

Gout, FINNGEN

112

388

2.88

23.78

1.2

0.75

0.67

g/l

0.05

Pain in throat and chest

281

844

1.97

22.84

1.2

0.31

0.51

g/l

0.46

Rheumatoid arthritis, including avohilmo

151

625

2.43

22.83

1.1

1.2

0.21

0.26

g/l

—

Transplanted organ and tissue status

140

4.26

22.74

1.5

1.1

0.48

0.14

g/l

—

Arthropathies

290

751

1.96

22.02

1.3

1.2

0.18

0.46

g/l

0.83

Symptoms and signs involving the circulatory and respiratory systems

324

864

1.88

22.01

1.2

0.24

0.51

g/l

0.85

Other pulmonary diagnosis

245

597

2.06

21.39

1.2

0.19

0.38

g/l

0.54

Pain (limb, back, neck, head abdominally)

217

505

2.16

21.27

1.3

1.2

0.22

0.21

g/l

0.04

Cardiac arrhythmias

199

592

2.16

20.91

1.2

0.23

0.60

g/l

0.89

Asthma-related infections

213

1028

2.03

20.65

1.2

0.19

0.38

g/l

—

Asthma, hospital admission 2, infections

213

1028

2.03

20.65

1.2

0.19

0.38

g/l

—

Diseases of the eye and adnexa

255

641

2.00

20.54

1.3

1.1

0.17

0.15

g/l

0.11

Other respiratory diseases principally affecting the interstitium

237

3.27

20.38

1.3

1.2

0.26

0.24

g/l

—

Other disorders of lacrimal gland

145

622

2.34

20.30

1.2

1.33

0.26

g/l

—

COPD differential diagnosis

241

596

2.03

20.28

1.2

0.19

0.38

g/l

0.54

ILD differential diagnosis

241

596

2.03

20.28

1.2

0.19

0.38

g/l

0.54

Genitourinary diseases

179

392

2.30

20.28

1.2

0.14

0.65

g/l

0.92

Excluding asthma or asthma-COPD overlap

241

597

2.03

20.19

1.2

0.20

0.38

g/l

0.50

Hard cardiovascular diseases

275

856

1.90

20.14

1.3

1.2

0.15

0.60

g/l

1.67

Disorders of lacrimal system

167

752

2.19

19.95

1.2

1.22

0.35

g/l

—

Amputation

124

4.23

19.94

1.4

1.2

1.05

0.30

g/l

—

Any reimbursement code in KELA

179

396

2.27

19.80

1.2

0.11

0.19

g/l

—

Parasetamol

222

543

2.07

19.74

1.3

1.2

0.22

0.50

g/l

0.55

Abnormal findings on diagnostic imaging of lung

170

744

2.17

19.71

1.4

1.2

0.27

0.62

g/l

0.95

Haemorrhage from respiratory passages

124

441

2.50

19.54

1.2

0.39

0.71

g/l

—

Methotrexate

144

3.91

19.41

1.1

1.2

1.09

0.24

g/l

—

Concussion

160

554

2.24

19.34

1.2

0.12

0.47

g/l

—

Stroke, excluding SAH

206

731

2.04

19.24

1.1

1.3

0.16

0.68

g/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

242

1140

1.90

19.23

1.2

0.67

0.50

g/l

0.16

Non-ischemic cardiomyopathy

115

352

2.60

19.20

1.2

0.42

0.58

g/l

0.18

Peripheral artery operations in Hilmo

137

3.97

19.06

1.4

1.2

0.91

0.28

g/l

—

Intracranial trauma

179

564

2.15

18.87

1.3

1.2

0.07

0.47

g/l

—

Stroke, including SAH

214

771

2.00

18.86

1.1

1.3

0.16

0.65

g/l

—

Visual disturbances and blindness

187

918

2.04

18.66

1.4

1.2

0.25

0.60

g/l

1.21

COPD/asthma/ILD related infections

311

866

1.80

18.55

1.2

0.27

0.60

g/l

0.81

COPD/asthma related infections

311

866

1.80

18.55

1.2

0.27

0.60

g/l

0.81

DVT of lower extremities and pulmonary embolism

148

663

2.23

18.53

1.3

1.2

0.55

0.34

g/l

—

Other interstitial pulmonary diseases

206

3.32

18.51

1.2

0.33

0.24

g/l

—

Intestinal infectious diseases

309

1310

1.76

18.50

1.2

0.53

0.47

g/l

0.07

Nerve, nerve root and plexus disorders

344

1204

1.72

18.28

1.3

1.2

0.51

0.47

g/l

0.06

Seropositive rheumatoid arthritis

328

2.77

18.12

1.1

1.2

0.24

0.21

g/l

—

Hypothyroidism, strict autoimmune

200

648

2.03

18.10

1.2

0.36

0.43

g/l

—

Peripheral arterial reconstruction

219

3.22

18.09

1.2

1.3

0.64

0.22

g/l

—

Other disorders of fluid, electrolyte and acid-base balance

115

440

2.47

17.99

1.5

1.2

0.62

0.17

g/l

0.44

Interstitial lung disease

212

3.23

17.70

1.2

0.33

0.22

g/l

—

Interstitial lung disease endpoints

212

3.23

17.70

1.2

0.33

0.22

g/l

—

Lower back pain or/and sciatica

348

1279

1.69

17.69

1.3

1.2

0.48

g/l

0.00

Pulmonary heart disease

112

456

2.47

17.67

1.2

0.53

0.21

g/l

—

Pulmonary embolism

112

456

2.47

17.67

1.2

0.53

0.21

g/l

—

Other disorders of urethra and urinary system

232

853

1.90

17.55

1.2

0.70

0.60

g/l

0.10

Injuries to the head

358

1265

1.68

17.55

1.2

0.11

0.58

g/l

2.72

Cutaneous abscess, furuncle and carbuncle

107

428

2.51

17.55

1.2

0.20

0.23

g/l

—

Asthma, including avohilmo

374

1236

1.67

17.53

1.2

1.09

0.39

g/l

0.59

Intestinal infectious diseases, including avohilmo, including avohilmo

361

1199

1.68

17.37

1.2

0.47

0.48

g/l

0.02

Atrial fibrillation and flutter

230

2.76

17.37

1.3

1.2

0.14

0.28

g/l

0.68

Disorders of other endocrine glands

158

738

2.11

17.30

1.2

0.33

0.25

g/l

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

295

1325

1.74

17.15

1.4

1.2

0.56

0.45

g/l

0.17

Subjective visual disturbances

104

416

2.51

17.07

1.5

1.2

0.30

g/l

—

Ischaemic Stroke, excluding all haemorrhages

189

695

2.01

17.04

1.1

1.3

0.17

0.64

g/l

—

Complications of medical and surgical care

245

1215

1.82

17.00

1.3

1.2

0.58

0.50

g/l

0.09

Asthma (diagnoses ohter than nonallergic)

285

1322

1.74

16.96

1.2

1.15

0.43

g/l

—

Atopic dermatitis

189

758

1.99

16.93

1.2

0.48

0.24

g/l

—

Spondylopathies

248

793

1.85

16.89

1.2

0.67

0.52

g/l

—

Pyoderma gangrenosum

17.63

16.87

1.4

1.0

—

g/l

—

Disorders of eyelid, lacrimal system and orbit

282

1179

1.76

16.86

1.2

0.68

0.48

g/l

0.21

Medical observation and evaluation for suspected diseases and conditions

193

483

2.05

16.79

1.2

0.74

0.22

g/l

—

Pulmonary heart disease, diseases of pulmonary circulation

117

498

2.36

16.76

1.1

1.2

0.53

0.22

g/l

—

Visual disturbances

173

862

2.01

16.69

1.4

1.2

0.25

0.43

g/l

0.63

ILD, hospital admissions

210

3.16

16.63

1.2

0.33

0.22

g/l

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

321

1217

1.69

16.49

1.2

0.56

0.48

g/l

0.09

Fall on same level

355

1138

1.67

16.44

1.2

0.40

0.45

g/l

0.06

Other special examinations and investigations of persons without complaint or reported diagnosis

193

483

2.03

16.38

1.3

1.2

0.20

0.22

g/l

0.08

Other dorsopathies, not elsewhere classified

305

915

1.73

16.25

1.2

0.44

0.54

g/l

0.13

Other joint disorders

261

751

1.82

16.20

1.2

0.32

0.46

g/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

197

1037

1.90

16.19

1.2

0.32

0.53

g/l

—

Syncope and collapse

128

473

2.26

16.15

1.1

1.2

0.53

0.51

g/l

—

Neurological diseases

245

666

1.85

15.99

1.2

0.27

0.43

g/l

0.40

Episodal and paroxysmal disorders

334

1007

1.68

15.98

1.2

0.28

0.41

g/l

0.37

Neoplasms

240

680

1.85

15.96

1.2

0.16

0.15

g/l

0.07

Endocrine, nutritional and metabolic diseases

235

636

1.87

15.84

1.3

1.2

0.24

0.25

g/l

0.05

Symptoms and signs involving speech and voice

124

557

2.24

15.71

1.2

0.73

0.16

g/l

—

Valvular heart disease excluding rheumatic fever

145

482

2.15

15.68

1.2

0.49

0.92

g/l

0.41

Polyarteritis nodosa

40.75

15.61

1.3

1.0

—

g/l

—

Sulfasalazine

346

2.58

15.53

1.2

0.18

0.22

g/l

—

Chronic lower respiratory diseases

370

1203

1.62

15.47

1.2

0.99

0.40

g/l

0.53

Non-rheumatic valve diseases

144

480

2.15

15.44

1.2

0.50

0.92

g/l

0.41

Varicose veins

185

720

1.94

15.42

1.2

0.66

0.65

g/l

—

Other bacterial intestinal infections

274

2.79

15.39

1.3

1.2

0.09

0.23

g/l

—

Spondylosis

174

689

1.98

15.33

1.3

1.2

0.91

0.55

g/l

—

Gout, unspecified

297

2.71

15.32

1.2

0.71

0.27

g/l

—

Mycoses, including avohilmo

294

1332

1.68

15.28

1.3

1.2

0.96

0.37

g/l

0.71

Gout, idiopatic and unspecified

361

2.53

15.25

1.2

0.64

0.46

g/l

—

Disorders of sclera, cornea, iris and ciliary body

189

1003

1.89

15.22

1.4

1.2

0.46

0.35

g/l

0.26

Mycoses

108

464

2.34

15.21

1.4

1.2

1.09

0.21

g/l

—

Cardiomyopathy

202

3.08

15.03

1.2

1.1

0.21

1.02

g/l

—

Other bacterial intestinal infections, including avohilmo

382

2.47

14.98

1.2

0.09

0.24

g/l

—

Gastrointestinal diseases

179

446

2.02

14.96

1.3

1.2

0.28

0.53

g/l

0.41

Cellulitis

359

2.52

14.93

1.3

1.2

0.17

0.24

g/l

—

Heart failure and coronary heart disease

140

459

2.14

14.89

1.2

0.13

0.72

g/l

1.58

Other and unspecified iron deficiency

123

562

2.19

14.89

1.3

1.2

0.78

0.21

g/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

200

1068

1.84

14.79

1.3

1.2

0.71

0.53

g/l

0.18

Fibromyalgia

103

4.01

14.75

1.1

1.2

—

0.09

g/l

—

Other diseases of urinary system

299

999

1.68

14.64

1.2

0.22

0.52

g/l

1.00

Myalgia

329

2.56

14.48

1.1

1.3

—

0.27

g/l

—

All influenza

383

2.44

14.41

1.2

0.15

0.30

g/l

—

Chronic gastritis

414

2.38

14.37

1.2

1.76

0.21

g/l

—

Falls/tendency to fall

325

989

1.65

14.36

1.2

0.12

0.47

g/l

1.80

Osteoporosis

367

2.41

14.31

1.4

1.1

1.33

0.27

g/l

—

Iron deficiency anaemia

143

694

2.03

14.10

1.2

0.78

0.21

g/l

—

Acute tubulo-interstitial nephritis

186

842

1.87

14.09

1.3

1.2

0.74

0.58

g/l

0.16

Diabetic nephropathy, excluding more controls

154

3.14

14.01

1.2

1.3

0.11

0.84

g/l

—

Other diseases of intestines

317

1081

1.64

13.95

1.2

0.23

0.45

g/l

0.72

Dorsopathies

301

916

1.67

13.91

1.2

0.21

0.54

g/l

1.07

Zoster [herpes zoster], including avohilmo

169

860

1.90

13.83

1.4

1.2

0.78

0.48

g/l

0.34

Bacterial pneumonia, not elsewhere classified

122

499

2.15

13.83

1.3

1.2

0.14

0.57

g/l

—

Abdominal and pelvic pain

293

879

1.68

13.82

1.2

0.53

0.38

g/l

0.18

Disorders of lipoprotein metabolism and other lipidaemias

244

854

1.74

13.74

1.2

0.16

0.31

g/l

0.70

Other and unspecified effects of external causes

104

460

2.27

13.74

1.2

0.15

0.21

g/l

—

Bacterial intestinal infections, IBD co-morbidities

280

2.66

13.70

1.3

1.2

0.09

0.35

g/l

—

Bacterial pneumoniae

127

531

2.10

13.61

1.3

1.2

0.14

0.78

g/l

—

338

1072

1.60

13.37

1.2

0.26

0.53

g/l

0.83

Enterocolitis due to Clostridium difficile

150

3.29

13.23

1.2

0.07

0.26

g/l

—

Mood disorders, excluding more controls

289

1035

1.64

13.14

1.3

1.2

0.73

0.49

g/l

—

Nutritional anaemias

160

804

1.90

13.11

1.3

1.2

0.94

0.20

g/l

0.76

Anxiety disorders, excluding more controls

259

985

1.68

13.11

1.3

1.2

0.44

0.50

g/l

0.11

Pure hypercholesterolaemia

221

799

1.76

13.08

1.3

1.2

0.15

0.33

g/l

0.78

Diseases of the respiratory system

186

494

1.89

13.06

1.2

0.22

0.42

g/l

0.43

Voice disturbances

433

2.27

13.01

1.2

0.78

0.13

g/l

—

Gout, strict definition

265

2.66

12.98

1.2

0.80

0.26

g/l

—

Other gastritis (incl. Duodenitis)

342

2.44

12.91

1.2

1.07

0.22

g/l

—

Sequelae of external causes of morbidity and mortality

437

2.25

12.74

1.2

0.06

0.33

g/l

—

Neurotic, stress-related and somatoform disorders

279

1182

1.63

12.66

1.3

1.2

0.41

0.52

g/l

0.17

Anxiety disorders

280

1184

1.62

12.59

1.3

1.2

0.44

0.52

g/l

0.13

Use of hypnotics and sedatives

323

1168

1.58

12.57

1.3

1.2

0.53

0.42

g/l

0.14

Viral infections characterized by skin and mucous membrane lesions

139

712

1.96

12.51

1.4

1.2

0.35

0.21

g/l

0.30

Diseases of oesophagus, stomach and duodenum

316

1179

1.58

12.45

1.2

0.67

0.34

g/l

0.39

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

295

1164

1.60

12.39

1.3

1.2

0.26

0.57

g/l

0.99

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

183

1025

1.78

12.38

1.3

1.2

0.71

0.52

g/l

0.19

Irritable bowel syndrome

101

462

2.19

12.36

1.3

1.2

0.41

0.23

g/l

—

Asthma, hospital admissions , main diagnosis only

251

1330

1.64

12.33

1.2

0.93

0.44

g/l

—

Non-follicular lymphoma

132

3.36

12.30

2.0

1.2

1.38

0.10

g/l

—

Constipation

270

1125

1.63

12.24

1.3

1.2

0.57

0.47

g/l

0.12

Factors influencing health status and contact with health services

150

2.65

12.18

1.2

0.08

0.14

g/l

—

Mood [affective] disorders

310

1261

1.58

12.18

1.2

0.67

0.46

g/l

0.17

Mood disorders

310

1261

1.57

12.09

1.2

0.67

0.46

g/l

0.17

Symptoms and signs involving the digestive system and abdomen

285

879

1.63

12.08

1.2

0.13

0.38

g/l

1.22

Other antidepressants

298

950

1.60

11.97

1.2

0.66

0.38

g/l

0.32

Type 2 diabetes, wide definition

236

886

1.68

11.96

1.2

0.12

0.55

g/l

1.94

Bacterial pneumonia (organism specified)

137

640

1.94

11.92

1.3

1.2

0.13

0.48

g/l

1.11

Psoriasis

100

468

2.14

11.59

1.2

0.05

0.22

g/l

—

Persons encountering health services for examination and investigation

177

483

1.84

11.55

1.3

1.2

0.23

0.22

g/l

0.03

Lymphoid leukaemia

4.21

11.53

1.8

1.3

0.31

0.29

g/l

—

Hypertensive heart and/or renal disease

238

2.43

11.48

1.1

1.2

0.19

0.51

g/l

—

General examination and investigation of persons without complaint and reported diagnosis

171

482

1.84

11.35

1.3

1.2

0.17

0.22

g/l

—

Other diseases of pleura

136

619

1.91

11.27

1.3

1.2

0.16

0.61

g/l

1.27

Care involving use of rehabilitation procedures

191

1001

1.72

11.21

1.3

1.2

0.11

0.60

g/l

—

Candidiasis, including avohilmo

106

515

2.07

11.16

1.2

0.60

0.18

g/l

—

Sequelae of cerebrovascular disease

114

482

2.03

11.08

1.1

1.2

0.21

0.46

g/l

—

Benzodiazepine use

300

1312

1.54

10.97

1.3

1.2

0.72

0.45

g/l

0.24

Bronchitis

322

1265

1.53

10.96

1.2

0.32

0.52

g/l

0.46

Atrial fibrillation and flutter with reimbursement

173

2.56

10.87

1.3

1.2

0.19

0.31

g/l

—

Anxiety (asthma-related co-morbidities)

195

870

1.71

10.86

1.3

1.2

0.54

0.32

g/l

—

Chronic lymphocytic leukaemia, helper endpoint

8.35

10.83

1.9

1.4

0.35

0.08

g/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

8.35

10.83

1.9

1.4

0.35

0.08

g/l

—

Chronic lymphocytic leukaemia

8.35

10.83

1.9

1.4

0.35

0.08

g/l

—

Viral pneumonia

186

2.81

10.82

1.3

1.2

0.16

0.30

g/l

—

Cystitis

243

889

1.63

10.80

1.2

0.30

0.58

g/l

0.67

Depression

285

1225

1.56

10.78

1.3

1.2

0.67

0.46

g/l

—

Other disorders of kidney and ureter

193

2.76

10.67

1.4

1.2

0.07

0.29

g/l

—

Disorders of choroid and retina

235

1016

1.62

10.62

1.2

0.78

0.43

g/l

0.34

All anxiety disorders

199

919

1.68

10.59

1.3

1.2

0.54

0.24

g/l

—

Other external causes of accidental injury

220

658

1.68

10.55

1.2

0.29

0.44

g/l

0.36

Soft tissue disorders related to use, overuse and pressure

402

2.17

10.46

1.2

0.07

0.25

g/l

—

Seropositive rheumatoid arthritis, wide

429

2.13

10.40

1.1

1.2

0.24

0.30

g/l

—

Other and unspecified local infections of skin and subcutaneous tissue

147

3.01

10.36

1.1

1.2

0.09

0.27

g/l

—

Triptan medication for migraine, min. 3 purchases

179

778

1.72

10.31

1.2

0.78

0.21

g/l

—

Acute upper respiratory infections

301

1188

1.52

10.04

1.2

0.27

0.51

g/l

0.73

Other acute lower respiratory infections

163

897

1.73

10.02

1.2

0.19

0.23

g/l

—

Papulosquamous disorders

127

683

1.86

10.02

1.1

1.2

0.05

0.28

g/l

—

Other inflammation of eyelid, including avohilmo

143

801

1.79

9.88

1.3

1.2

0.38

0.25

g/l

—

Other diseases of lip and oral mucosa

135

744

1.82

9.86

1.3

1.2

0.12

0.36

g/l

—

Other local infections of skin and subcutaneous tissue

157

2.88

9.83

1.1

1.2

0.09

0.27

g/l

—

Accidents

216

658

1.65

9.72

1.2

0.27

0.44

g/l

0.46

Nausea and vomiting

397

2.12

9.71

1.4

1.2

0.38

0.26

g/l

—

Diabetic nephropathy

241

2.47

9.69

1.2

0.11

0.55

g/l

—

Acute bronchitis

125

667

1.84

9.49

1.3

1.2

0.16

0.27

g/l

—

Disorders of gallbladder, biliary tract and pancreas

283

1165

1.51

9.36

1.3

1.2

0.27

0.57

g/l

0.96

Adverse effects, not elsewhere classified

317

2.25

9.34

1.3

1.2

0.14

0.21

g/l

—

Iridocyclitis

364

2.15

9.21

1.4

1.2

0.45

0.27

g/l

—

Depression or dysthymia

187

613

1.67

9.06

1.2

0.63

0.36

g/l

0.22

Acute upper respiratory infections of multiple and unspecified sites

225

1048

1.57

9.01

1.2

0.36

0.46

g/l

0.18

Persons encountering health services in other circumstances

116

621

1.85

9.00

1.1

1.2

0.26

0.34

g/l

—

Benign neoplasms

281

1014

1.51

8.98

1.2

0.15

0.42

g/l

1.23

Chronic apical periodontitis

318

1216

1.47

8.92

1.3

1.2

0.68

0.28

g/l

0.85

Symptoms and signs involving the urinary system

218

1047

1.57

8.89

1.4

1.2

1.03

0.34

g/l

0.93

Other neurological diseases

207

1011

1.59

8.89

1.1

1.2

0.20

0.56

g/l

—

Persons with potential health hazards related to communicable diseases

121

661

1.82

8.86

1.1

1.2

0.96

0.21

g/l

—

Zoster [herpes zoster]

274

2.31

8.83

1.5

1.2

0.58

0.23

g/l

—

Other/unspecified seropositive rheumatoid arthritis

424

2.04

8.81

1.1

1.2

0.24

0.30

g/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

418

2.04

8.77

1.1

1.2

0.24

0.30

g/l

—

Urinary track infection

172

509

1.70

8.68

1.2

0.28

0.50

g/l

—

Other anxiety disorders

146

724

1.72

8.63

1.3

1.2

0.58

0.24

g/l

—

Intracranial injury

169

959

1.64

8.59

1.2

1.3

0.12

0.53

g/l

—

Statin medication

203

713

1.61

8.55

1.2

0.12

0.46

g/l

—

Injuries to the knee and lower leg

336

1262

1.44

8.51

1.2

0.70

0.44

g/l

0.27

Paroxysmal tachycardia

213

2.35

8.44

1.2

0.11

0.32

g/l

—

Disorders of skin appendages

155

926

1.67

8.42

1.2

0.42

0.23

g/l

—

Injuries to the thorax

137

797

1.72

8.36

1.3

1.2

0.86

0.38

g/l

—

COPD (mode)

285

2.11

8.33

1.2

1.19

0.38

g/l

—

External causes of morbidity and mortality

172

516

1.67

8.30

1.2

0.24

0.32

g/l

0.21

Symptoms and signs concerning food and fluid intake

112

3.04

8.22

1.2

1.1

—

0.08

g/l

—

Hypertensive Heart Disease

220

2.25

8.14

1.1

1.2

0.21

0.47

g/l

—

Disorders of the thyroid gland

265

1163

1.48

8.01

1.2

0.41

0.48

g/l

0.10

Candidiasis

230

2.36

7.98

1.1

1.2

0.71

0.22

g/l

—

Superficial injury of head

372

2.05

7.95

1.1

1.2

0.17

0.33

g/l

—

Operations 2 for CAVS

405

1.98

7.86

1.3

1.2

0.61

0.54

g/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

405

1.98

7.86

1.3

1.2

0.61

0.54

g/l

—

Disorders of lens

180

695

1.61

7.85

1.4

1.2

0.28

0.49

g/l

0.46

Asthma and allergy, excluding more controls

158

2.63

7.82

1.1

1.2

—

0.17

—

Other functional intestinal disorders

128

675

1.73

7.81

1.3

1.2

0.16

0.38

g/l

—

Calcific aortic valvular stenosis

406

1.97

7.81

1.3

1.2

0.61

0.54

g/l

—

Calcific aortic valvular stenosis, operated

406

1.97

7.81

1.3

1.2

0.61

0.54

g/l

—

Calcific aortic valvular stenosis, including rheumatic fever

406

1.97

7.78

1.3

1.2

0.61

0.54

g/l

—

Asthma and allergy

159

2.62

7.72

1.1

1.2

—

0.17

—

Injury, poisoning and certain other consequences of external causes

147

432

1.71

7.69

1.3

1.2

0.24

0.32

g/l

0.21

Bullous disorders

3.28

7.66

1.1

1.4

—

0.32

g/l

—

Any death

174

762

1.60

7.61

1.2

1.3

0.25

0.68

g/l

1.27

Diverticular disease of intestine

188

744

1.57

7.55

1.2

1.01

0.49

g/l

0.42

Selective serotonin reuptake inhibitors

268

951

1.47

7.47

1.2

0.42

0.38

g/l

0.08

Substance abuse, excluding more controls

154

792

1.63

7.46

1.3

1.2

0.16

0.33

g/l

—

Any mental disorder

300

1048

1.43

7.41

1.2

0.71

0.48

g/l

0.22

Insulin, fast-acting

106

595

1.78

7.40

1.2

0.10

0.44

g/l

1.18

Irregular menses

145

659

1.66

7.38

1.2

1.18

0.43

g/l

—

Rosacea

208

2.37

7.33

1.2

—

0.15

g/l

—

Senile cataract

160

599

1.63

7.30

1.5

1.2

0.32

0.55

g/l

0.43

Insulin, combination of fast acting with intermediate-acting or long-acting

169

973

1.58

7.30

1.2

0.09

0.47

g/l

1.94

Malignant neoplasm

235

924

1.49

7.30

1.3

1.2

0.44

0.13

g/l

0.99

Pleural effusion

215

2.33

7.27

1.2

0.18

0.24

g/l

—

Other abnormal findings of blood chemistry

3.41

7.25

3.3

1.2

2.12

0.06

g/l

—

Disorders of conjunctiva

240

1269

1.47

7.22

1.2

0.58

0.48

g/l

—

Sciatica+with lumbago

145

787

1.63

7.22

1.3

1.2

0.26

0.55

g/l

—

Malignant neoplasm

234

922

1.49

7.20

1.3

1.2

0.44

0.13

g/l

0.99

Diseases of the digestive system

126

744

1.68

7.17

1.2

1.55

0.42

g/l

—

Periodontitis

279

1243

1.43

7.16

1.3

1.2

1.00

0.32

g/l

1.07

Malignant neoplasm, wide definition

239

941

1.48

7.15

1.3

1.2

0.45

0.15

g/l

0.96

Other nutritional deficiencies

196

1181

1.52

7.15

1.2

0.13

0.51

g/l

—

Malignant neoplasm, including Hilmo

238

939

1.48

7.08

1.2

0.45

0.15

g/l

0.96

Chronic periodontitis, including avohilmo

278

1243

1.43

7.05

1.3

1.2

1.00

0.32

g/l

1.07

Hypothyreosis and Thyroxine purchase for inclusion criteria

255

1154

1.45

7.01

1.2

0.57

0.46

g/l

—

Other retinal disorders

174

848

1.56

7.01

1.3

1.2

1.03

0.47

g/l

0.44

Non-selective monoamine reuptake inhibitors

106

580

1.76

7.00

1.2

1.32

0.31

g/l

—

Insulin, fast-acting or short human

106

606

1.75

6.98

1.2

0.10

0.44

g/l

1.18

Symptoms and signs involving cognition, perception, emotional state and behaviour

268

1251

1.43

6.98

1.2

0.82

0.43

g/l

0.44

Other intervertebral disc disorders

216

859

1.50

6.97

1.2

0.41

0.55

g/l

—

Ischemic heart diseases

222

887

1.49

6.95

1.3

1.2

0.37

0.59

g/l

0.34

Insulin, intermediate and long-acting

151

915

1.59

6.92

1.1

1.2

0.09

0.50

g/l

1.89

Insulin medication

169

900

1.56

6.90

1.2

0.09

0.37

g/l

1.80

Secondary and unspecified malignant neoplasm of lymph nodes

108

2.89

6.89

1.4

1.2

1.01

0.06

g/l

—

Other erythematous conditions

3.92

6.72

1.3

1.2

—

0.12

—

Meniscus derangement

141

574

1.63

6.69

1.2

1.87

0.45

g/l

—

Conjunctivitis (acute, non atopic), including avohilmo

275

1172

1.42

6.67

1.1

1.2

0.20

0.48

g/l

1.35

Other cataract

120

529

1.69

6.62

1.2

0.09

0.41

g/l

—

Other medical care

130

665

1.64

6.60

1.2

0.74

0.79

g/l

—

Hypothyroidism, other/unspecified

242

1105

1.44

6.52

1.2

0.63

0.50

g/l

—

Fracture of rib(s), sternum and thoracic spine

487

1.81

6.51

1.3

1.2

1.15

0.29

g/l

—

Diseases of salivary glands

561

1.75

6.48

1.2

0.21

0.26

g/l

—

Conjunctivitis

217

1200

1.46

6.41

1.1

1.2

0.70

0.35

g/l

—

Coxarthrosis [arthrosis of hip](FG)

122

503

1.67

6.40

1.4

1.2

0.28

0.36

g/l

—

Unspecified haematuria

114

551

1.69

6.39

1.5

1.2

0.98

0.16

g/l

—

Haemophagocytic lymphohistiocytosis

+∞

6.37

1.3

0.0

—

g/l

—

Type 1 diabetes

397

1.89

6.36

1.2

0.09

0.23

g/l

—

Sleep disorders (combined)

296

1112

1.39

6.30

1.2

0.28

0.48

g/l

0.58

Disorders of synovium and tendon

137

730

1.59

6.21

1.2

0.56

0.48

g/l

—

Ganglion

284

2.05

6.18

1.1

1.2

—

0.13

g/l

—

Any event in cancer register

247

1015

1.42

6.10

1.2

0.44

0.15

g/l

0.91

Follow-up examination after treatment for conditions other than malignant neoplasms

107

418

1.71

6.06

1.2

0.21

0.22

g/l

—

Migraine without aura and triptan purchases

262

2.07

5.92

1.1

1.3

—

0.21

g/l

—

Shoulder lesions

185

743

1.49

5.92

1.2

0.77

0.46

g/l

—

Diabetes mellitus

274

1144

1.38

5.81

1.3

1.2

0.15

0.53

g/l

2.08

Substance abuse

154

943

1.52

5.76

1.3

1.2

0.16

0.42

g/l

—

Dysphagia

362

1.88

5.74

1.1

1.2

0.18

0.29

g/l

—

Anterior Iridocyclitis

328

1.93

5.69

1.5

1.2

0.45

0.16

g/l

—

DVT of lower extremities

253

2.06

5.67

1.5

1.2

0.37

0.32

g/l

—

Open wound of head

141

860

1.54

5.66

1.1

1.2

0.16

0.45

g/l

—

Temporomandibular joint disorders, including avohilmo

130

804

1.57

5.65

1.1

1.2

0.99

0.33

g/l

—

Type 2 diabetes

263

1099

1.39

5.65

1.3

1.2

0.15

0.56

g/l

2.10

Mental and behavioural disorders due to psychoactive substance use

158

965

1.50

5.60

1.3

1.2

0.15

0.41

g/l

1.07

Other diseases of upper respiratory tract

286

1089

1.37

5.59

1.2

1.3

0.66

0.45

g/l

0.24

Rotator cuff syndrome

149

670

1.53

5.56

1.3

1.2

0.84

0.43

g/l

—

107

589

1.64

5.50

1.2

1.11

0.36

g/l

—

5-aminosalicylic acid

237

2.07

5.44

1.2

—

0.26

g/l

—

Dermatophytosis, including avohilmo

178

1201

1.45

5.43

1.3

1.2

1.48

0.38

g/l

—

Open wound of ankle and foot

160

2.32

5.41

1.4

1.1

0.51

0.11

g/l

—

Lumbar disc prolapse

166

829

1.48

5.41

1.2

0.38

0.55

g/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

155

995

1.49

5.41

1.2

1.05

0.28

g/l

—

Myelodysplastic syndrome, including Hilmo

5.22

5.40

1.2

1.3

—

0.06

g/l

—

Keratitis

102

623

1.64

5.39

1.2

0.33

0.23

g/l

—

Olecranon bursitis

3.03

5.37

1.2

—

0.18

g/l

—

Demyelinating diseases of the central nervous system

142

2.41

5.37

1.2

—

0.11

g/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

210

1002

1.42

5.37

1.3

1.2

0.25

g/l

—

Triptan medication for migraine, single purchase ok

210

1002

1.42

5.37

1.3

1.2

0.25

g/l

—

Nonischemic cardiomyopathy

142

2.40

5.36

1.2

0.64

0.44

g/l

—

GI-bleeding

496

1.72

5.33

1.3

1.2

1.78

0.31

g/l

—

Acute and subacute iridocyclitis

308

1.92

5.32

1.5

1.2

0.45

0.16

g/l

—

Other and unspecified rosacea

149

2.36

5.31

1.1

1.2

—

0.15

g/l

—

Obesity and other hyperalimentation

178

1159

1.45

5.25

1.2

0.13

0.54

g/l

—

Diabetes, varying definitions

269

1146

1.36

5.22

1.3

1.2

0.15

0.53

g/l

2.08

Sleep apnoea

253

1168

1.37

5.10

1.2

0.71

0.45

g/l

0.26

Transient ischemic attack

133

693

1.53

5.09

1.1

1.3

0.25

0.70

g/l

—

Unspecified fall

137

892

1.51

5.07

1.2

0.11

0.33

g/l

—

Allergic conjunctivitis

160

1054

1.46

5.05

1.2

1.05

0.27

g/l

—

Mental and behavioural disorders due to sedatives or hypnotics

110

2.56

5.04

1.3

1.1

—

0.05

—

Benign neoplasm of colon, rectum, anus and anal canal

163

944

1.46

5.04

1.2

0.21

0.59

g/l

—

Crohn's disease NAS

2.64

4.98

1.2

—

0.06

—

Etanercept

2.64

4.98

1.0

1.1

—

0.11

g/l

—

Retinal detachments and breaks

561

1.64

4.93

1.2

0.16

0.42

g/l

—

Ischaemic heart disease, wide definition

194

842

1.42

4.89

1.2

0.37

0.52

g/l

0.21

Weight loss

149

2.29

4.85

1.2

1.3

—

0.21

g/l

—

Obesity

175

1157

1.43

4.83

1.2

0.13

0.54

g/l

—

Cholelithiasis

217

1071

1.38

4.83

1.2

0.29

0.60

g/l

0.95

Presence of other functional implants

147

679

1.48

4.77

1.3

1.2

0.36

0.73

g/l

0.66

Gastro-oesophageal reflux disease

174

1030

1.43

4.76

1.2

0.81

0.32

g/l

0.52

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

590

1.61

4.75

1.1

1.2

0.54

0.20

g/l

—

COPD

107

552

1.58

4.71

1.2

0.88

0.32

g/l

—

Psychiatric diseases

249

918

1.36

4.70

1.2

0.17

0.52

g/l

1.50

Hyperlipidaemia, other/unspecified

544

1.60

4.68

1.3

1.2

1.16

0.39

g/l

—

Actinic keratosis

544

1.61

4.67

1.3

1.2

1.26

0.38

g/l

—

Secondary uncertain malignant neoplasm

165

2.19

4.64

1.3

1.2

1.00

0.10

g/l

—

Arthrosis

169

642

1.44

4.60

1.2

0.20

0.48

g/l

—

Skin changes due to chronic exposure to nonionizing radiation

558

1.59

4.59

1.3

1.2

1.26

0.38

g/l

—

Cardiodefibrillation

532

1.63

4.58

1.2

0.12

0.69

g/l

—

Striking against or struck by other objects

587

1.60

4.58

1.2

0.07

0.20

g/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

217

1065

1.37

4.56

1.2

0.29

0.48

g/l

—

Cholelithiasis, broad definition with cholecystitis

223

1090

1.36

4.52

1.3

1.2

0.31

0.59

g/l

0.80

Chronic periodontitis, complicated

148

1001

1.44

4.43

1.4

1.2

0.76

0.37

g/l

0.50

Exposure to other and unspecified forces of nature

7.73

4.39

1.3

1.0

—

Other diseases of the digestive system

494

1.64

4.38

1.3

1.2

1.78

0.31

g/l

—

Atypical facial pain

2.90

4.33

1.3

—

0.37

g/l

—

Transport accidents

111

605

1.53

4.33

1.3

1.2

1.04

0.39

g/l

—

Melanocytic naevi

537

1.60

4.25

1.2

0.12

0.21

g/l

—

Trigeminal neuralgia

2.71

4.25

1.1

1.3

—

0.36

g/l

—

Other Crohn's disease

114

2.38

4.23

1.1

—

0.06

g/l

—

Visual impairment including blindness (binocular or monocular)

2.57

4.21

1.2

1.3

—

0.29

g/l

—

Diseases of pulp and periapical tissues, including avohilmo

265

1039

1.32

4.19

1.3

1.2

0.37

0.28

g/l

0.21

Other symptoms and signs involving cognitive functions and awareness

120

716

1.49

4.17

1.2

1.02

0.44

g/l

—

Other chronic obstructive pulmonary disease

101

535

1.55

4.16

1.2

1.00

0.31

g/l

—

Occupational exposure to risk-factors

3.01

4.13

1.1

1.2

—

0.07

g/l

—

Percutaneous Coronary Intervention

192

850

1.37

4.10

1.4

1.2

0.16

0.59

g/l

1.70

Paracetamol or NSAID medication

2.16

4.09

1.0

1.2

—

0.12

g/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

138

749

1.45

4.09

1.2

1.3

0.09

0.56

g/l

—

Degeneration of macula and posterior pole

118

612

1.49

4.06

1.2

0.90

0.53

g/l

—

Systemic disorders of connective tissue in diseases classified elsewhere

10.42

4.05

1.3

1.1

—

Crohn disease

216

1.95

4.04

1.1

1.2

—

0.23

g/l

—

Personality disorders, excluding more controls

406

1.67

3.99

1.6

1.2

0.29

0.22

g/l

—

Missing teeth due to accident, extraction or parodontitis

158

1012

1.40

3.94

1.2

0.27

0.56

g/l

1.05

Polycystic ovarian syndrome, consortium definition

187

782

1.37

3.94

1.2

0.30

0.41

g/l

—

150

929

1.41

3.89

1.2

0.14

0.41

g/l

1.04

Diseases of pulp and periapical tissues and dental caries

162

591

1.41

3.86

1.2

0.12

0.23

g/l

0.87

Malignant neoplasm of skin, including Hilmo

125

573

1.46

3.85

1.2

0.49

0.13

g/l

—

Other diseases of hard tissues of teeth

137

491

1.45

3.81

1.1

0.42

0.26

g/l

—

Diseases of oral cavity, salivary glands and jaws

138

493

1.44

3.79

1.2

1.1

0.10

0.26

g/l

1.31

Major coronary heart disease event

204

909

1.34

3.79

1.3

1.2

0.40

0.55

g/l

0.21

Orchitis and epididymitis

127

2.21

3.75

1.2

—

0.12

g/l

—

Diaphragmatic hernia

595

1.53

3.74

1.4

1.2

1.03

0.35

g/l

—

Other disorders of optic [2nd] nerve and visual pathways

2.41

3.72

1.3

1.2

—

0.10

g/l

—

COPD related to multimorbidity

521

1.53

3.72

1.1

1.2

0.14

0.47

g/l

—

143

912

1.40

3.68

1.2

0.15

0.42

g/l

0.98

Sub-endpoint used in defining T1D endpoints

463

1.60

3.68

1.2

0.09

0.22

g/l

—

Vasomotor and allergic rhinitis

646

1.50

3.68

1.1

1.3

—

0.23

g/l

—

Malignant neoplasm of skin

117

542

1.46

3.64

1.2

0.49

0.13

g/l

—

Carpal tunnel syndrome

153

960

1.38

3.62

1.2

0.20

0.53

g/l

—

Coxarthrosis

109

475

1.48

3.60

1.4

1.2

0.32

0.48

g/l

—

Other chronic obstructive pulmonary disease, including avohilmo

128

738

1.43

3.59

1.3

1.2

0.66

0.41

g/l

0.21

Pacemaker

513

1.54

3.58

1.2

0.09

0.45

g/l

—

Aortic aneurysm

271

1.78

3.57

1.2

0.13

0.52

g/l

—

Excessive vomiting in pregnancy

131

2.15

3.51

1.2

—

0.18

g/l

—

MS-disease / Multiple Sclerosis

118

2.21

3.50

1.2

1.1

—

0.07

g/l

—

Coronary revascularization (ANGIO or CABG)

188

852

1.34

3.50

1.4

1.2

0.16

0.59

g/l

1.70

Seborrhoeic keratosis

301

1.73

3.49

1.2

1.59

0.18

g/l

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

167

1126

1.35

3.49

1.2

0.14

0.28

g/l

—

Abnormal weight loss

138

2.11

3.48

1.2

1.3

—

0.24

g/l

—

Suggestive for eosinophilic asthma

125

2.17

3.47

1.1

1.3

—

0.26

g/l

—

Benign neoplasm: Colon

131

876

1.40

3.47

1.3

1.2

0.23

0.60

g/l

—

Dental caries, including avohilmo

179

677

1.35

3.45

1.2

0.33

0.35

g/l

0.03

Other disorders of ear

231

1152

1.30

3.43

1.2

0.74

0.45

g/l

0.29

Basal cell carcinoma

102

470

1.48

3.41

1.2

0.61

0.14

g/l

—

Alcohol use disorder, Swedish definition

134

874

1.39

3.40

1.2

0.15

0.44

g/l

1.04

Disorders of vitreous body

127

861

1.40

3.38

1.3

1.2

0.20

0.61

g/l

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

5.83

3.36

1.1

—

Basal cell carcinoma, including Hilmo

106

491

1.46

3.34

1.2

0.61

0.14

g/l

—

Disorders of vitreous body and globe

129

874

1.40

3.33

1.3

1.2

0.17

0.60

g/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

231

1061

1.29

3.32

1.2

0.10

0.55

g/l

2.50

Obesity due to excess calories

125

894

1.40

3.30

1.2

0.13

0.29

g/l

—

Allergic rhinitis

526

1.52

3.28

1.1

1.2

—

0.22

g/l

—

Open wound of forearm

142

2.05

3.25

1.1

1.2

—

0.23

—

Crohn disease (strict definition, require KELA)

103

2.24

3.22

1.2

1.1

—

0.06

g/l

—

Fracture of lower leg, including ankle

138

989

1.37

3.21

1.3

1.2

0.77

0.44

g/l

—

Sleep apnoea, including avohilmo

254

1210

1.27

3.20

1.2

0.71

0.45

g/l

0.27

Dizziness and giddiness

185

1098

1.31

3.11

1.2

0.38

0.44

g/l

—

Perineal laceration during delivery

258

0.37

3.11

1.1

1.2

—

0.19

—

Congenital malformations, deformations and chromosomal abnormalities

149

1051

1.34

3.07

1.2

0.14

0.30

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

108

510

1.43

3.06

1.1

1.2

0.63

0.13

g/l

—

Other hearing loss

424

1.56

3.05

1.4

1.2

0.31

0.18

g/l

—

Other viral diseases, not elsewhere classified

290

1.69

3.05

1.1

1.2

—

0.20

g/l

—

In situ neoplasms

691

1.43

3.03

1.2

0.32

0.26

g/l

—

COPD, early/later onset

102

598

1.43

3.02

1.2

1.00

0.46

g/l

—

Hypersplenism

10.26

3.00

1.2

1.0

—

Necrotizing fasciitis

10.20

2.99

1.2

1.0

—

COPD, hospital admissions

101

595

1.43

2.98

1.2

1.00

0.46

g/l

—

Emergency coronary revascularization (for ACS)

201

939

1.29

2.96

1.3

1.2

0.16

0.62

g/l

1.93

Asthma and opportunity respiratory infection

2.55

2.96

1.2

1.3

—

0.43

—

Crohn disease (strict definition, require KELA, min 2 HDR)

101

2.19

2.93

1.2

1.1

—

0.06

g/l

—

Coronary atherosclerosis

146

684

1.35

2.89

1.3

1.2

0.37

0.69

g/l

0.45

Need for other prophylactic measures

2.26

2.87

1.2

—

0.12

—

Other and unspecified glaucoma

102

2.17

2.86

1.1

1.2

—

0.11

g/l

—

Cholecystectomy

173

1129

1.30

2.84

1.2

0.36

0.57

g/l

—

Obesity, other/unspecified

626

1.44

2.83

1.1

1.2

—

0.23

g/l

—

Nail disorders

130

2.01

2.80

1.0

1.2

—

0.13

—

Type 2 diabetes, definitions combined

231

1066

1.26

2.80

1.3

1.2

0.19

0.57

g/l

1.80

Caries of dentine, including avohilmo

189

745

1.30

2.80

1.2

0.32

0.34

g/l

0.02

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

125

889

1.36

2.78

1.2

1.3

0.81

0.41

g/l

—

Other or unspecified immunodeficiency

8.57

2.77

1.0

—

g/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

2.17

2.76

1.1

1.2

—

0.20

g/l

—

Other pleural conditions

138

1.96

2.74

1.7

1.2

0.24

0.33

g/l

—

Type 2 diabetes, definitions combined, including avohilmo

232

1068

1.26

2.73

1.3

1.2

0.19

0.57

g/l

1.77

Gingivitis and periodontal diseases

234

961

1.26

2.73

1.2

0.31

0.26

g/l

0.09

Myocardial infarction

110

554

1.39

2.70

1.2

0.52

0.82

g/l

—

Type 2 diabetes, strict (exclude DM1)

231

1072

1.25

2.69

1.3

1.2

0.19

0.56

g/l

1.78

Injuries to the ankle and foot

184

1228

1.28

2.68

1.3

1.2

0.71

0.35

g/l

0.39

Dental operations

145

558

1.34

2.67

1.2

0.14

0.24

g/l

—

Major coronary heart disease event excluding revascularizations

137

676

1.34

2.65

1.2

0.53

0.69

g/l

—

Haemorrhoids and perianal venous thrombosis

540

1.45

2.64

1.2

0.76

0.56

g/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

205

1.76

2.64

1.3

1.2

1.00

0.13

g/l

—

Diseases of the ear and mastoid process

285

1166

1.23

2.62

1.2

0.25

0.47

g/l

0.70

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

2.21

2.62

1.2

1.4

—

0.30

—

Diabetes, insulin treatment (Kela reimbursement)

245

1175

1.24

2.62

1.2

0.10

0.53

g/l

2.66

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

113

2.04

2.61

1.2

1.1

—

0.06

g/l

—

Injuries to the shoulder and upper arm

208

1276

1.26

2.61

1.2

0.63

0.45

g/l

0.16

Type 1 diabetes, wide definition, subgroup 1

337

1.57

2.57

1.2

0.09

0.24

g/l

—

Hypertensive encephalopathy

7.35

2.57

1.0

—

Presence of cardiac and vascular implants and grafts

498

1.40

2.53

1.2

0.11

0.81

g/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

235

1285

1.24

2.52

1.2

0.12

0.53

g/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

150

1.87

2.51

1.1

1.3

—

0.21

g/l

—

Unspecific neurodegenerative disorder

482

0.62

2.50

1.3

1.2

1.16

0.46

g/l

—

Osteonecrosis due to drugs

3.85

2.47

1.1

1.0

—

Disorders of adult personality and behaviour

495

1.46

2.46

1.5

1.2

0.25

0.21

g/l

—

ILD-related respiratory insufficiency

2.68

2.45

1.1

1.4

—

0.06

g/l

—

Other disorders of eyelid

679

1.38

2.45

1.2

0.22

0.46

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

486

1.38

2.41

1.1

1.2

0.71

0.14

g/l

—

Malignant neoplasm of brain, including Hilmo

0.00

2.40

0.0

1.2

—

0.07

—

Disorders of adrenal gland, other and/or unspecified

6.37

2.38

1.4

1.1

—

g/l

—

Complications peculiar to reattachment and amputation

6.34

2.38

1.2

1.1

—

g/l

—

Lichen simplex chronicus and prurigo

2.22

2.37

1.1

1.2

—

0.14

—

Use of amantadine

3.67

2.37

1.0

—

g/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

3.66

2.37

1.0

—

Fall on same level involving ice and snow

144

1114

1.29

2.36

1.3

1.2

0.45

0.51

g/l

—

Other shoulder lesions

111

1.99

2.35

1.0

1.2

—

0.10

g/l

—

Personality disorders

469

1.45

2.30

1.6

1.2

0.29

0.23

g/l

—

Disease of hard tissues of teeth, NOS

123

483

1.33

2.29

1.1

0.09

0.26

g/l

—

Spondylolisthesis/Spondylolysis

261

1.61

2.28

1.2

—

0.17

g/l

—

Autoimmune hepatitis

4.67

2.28

1.0

—

Unspecified/other endometriosis

131

1.87

2.26

1.1

1.2

—

0.17

g/l

—

Acute pancreatitis

302

1.56

2.23

1.1

1.2

0.21

0.26

g/l

—

Cholinergic urticaria

5.67

2.22

1.2

1.0

—

g/l

—

Malignant neoplasm of bone and articular cartilage

5.61

2.22

1.2

1.0

—

150

1.80

2.19

1.3

1.2

—

0.22

—

Crohn's disease of large intestine

2.13

2.18

1.2

1.1

—

0.05

—

Benign neoplasm of bone and articular cartilage

136

1.84

2.17

1.1

1.2

—

0.24

—

Hernia

223

1213

1.22

2.17

1.3

1.2

0.60

0.47

g/l

0.14

Use of donepezil

269

0.46

2.16

1.2

—

0.36

g/l

—

Polyp of the female genital tract

307

1.42

2.16

1.2

0.54

g/l

—

Glucosamine medication

102

607

1.34

2.15

1.2

0.36

0.50

g/l

—

Type 1 diabetes, wide definition

353

1.50

2.14

1.2

0.09

0.24

g/l

—

Herpesviral [herpes simplex] infections

189

1.70

2.13

1.3

1.2

—

0.28

g/l

—

Retention of urine

431

1.41

2.12

1.2

0.25

0.14

g/l

—

Other disorders of glucose regulation and pancreatic internal secretion

123

1.88

2.11

1.2

—

0.10

g/l

—

Thyroiditis

109

1.93

2.10

1.1

1.3

—

0.27

g/l

—

Chondropathies

252

1.59

2.08

1.1

1.2

—

0.22

g/l

—

Injuries to the elbow and forearm

174

1200

1.24

2.08

1.2

0.99

0.44

g/l

—

Degenerative macular diseases

153

1.77

2.07

1.1

1.3

—

0.45

—

IBD patients in KELA-register

365

1.48

2.06

1.2

—

0.22

g/l

—

Eosinophilic disease (BM)

3.53

2.06

1.1

—

Injury of other and unspecified intrathoracic organs

1.99

2.05

1.1

—

0.07

g/l

—

Fracture of foot, except ankle

416

1.44

2.02

1.5

1.2

1.11

0.24

g/l

—

Seborrhoeic dermatitis

125

1.84

2.02

1.1

1.2

—

0.11

—

Caries of enamel

234

1270

1.21

2.01

1.2

0.76

0.43

g/l

0.35

Exposure to other specified factors

196

1378

1.22

2.00

1.3

1.2

0.12

0.48

g/l

2.23

Fracture of shoulder and upper arm

627

1.36

1.99

1.2

0.17

0.26

g/l

—

Bacterial, viral and other infectious agents, including avohilmo

148

1.76

1.98

1.3

1.2

—

0.10

g/l

—

Other and unspecified disorders of binocular movement

4.62

1.95

1.0

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

4.62

1.95

1.0

1.1

—

Dental pulpitis, including avohilmo

225

1197

1.20

1.92

1.3

1.2

0.29

0.46

g/l

—

Dentofacial anomalies [including malocclusion]

174

1106

1.23

1.91

1.2

1.50

0.26

g/l

—

Other symptoms and signs involving the urinary system

143

1.75

1.88

1.1

1.2

—

0.09

g/l

—

Malignant neoplasm of brain

0.00

1.88

0.0

1.2

—

0.07

—

Mental and behavioural disorders due to alcohol

114

844

1.29

1.88

1.2

0.14

0.42

g/l

—

Diseases of male genital organs

107

410

1.32

1.87

1.2

0.16

0.58

g/l

—

Injuries to the hip and thigh

108

748

1.30

1.85

1.3

1.2

0.76

0.38

g/l

—

Endometriosis of pelvic peritoneum

244

1.53

1.82

1.0

1.2

—

0.47

g/l

—

Acute pharyngitis

243

1.55

1.82

1.1

1.2

—

0.14

g/l

—

Necrosis of pulp, including avohilmo

140

1110

1.25

1.80

1.1

1.2

0.71

0.43

g/l

—

Sleep disorders

219

1262

1.19

1.78

1.2

0.11

0.54

g/l

—

Medicines for HER+ breast cancer

599

0.68

1.77

1.4

1.2

0.44

0.53

g/l

—

Myocardial infarction, without ST-elevation

547

1.34

1.76

1.2

0.06

0.65

g/l

—

Acute pancreatitis (for exclusion)

321

1.47

1.75

1.1

1.2

0.21

0.23

g/l

—

Mature T/NK-cell lymphomas, hilmo

3.36

1.75

1.0

1.1

—

g/l

—

Crohn's disease of small intestine

117

1.80

1.74

1.2

—

0.10

g/l

—

Inflammatory bowel disease, strict (require KELA)

380

1.42

1.73

1.2

—

0.22

g/l

—

Uterine polyps

297

1.38

1.72

1.2

0.18

0.54

g/l

—

Benign neoplasm of breast

186

1.62

1.71

1.2

—

0.30

g/l

—

Tinnitus

398

1.41

1.70

1.1

1.2

—

0.18

g/l

—

Alcohol use disorder, ICD-based

690

1.31

1.69

1.2

0.16

0.47

g/l

—

Exposure to other and unspecified inanimate mechanical forces

126

1.75

1.67

1.2

—

0.10

g/l

—

Other pulmonary heart/vessel disease

2.04

1.64

1.0

1.3

—

0.10

g/l

—

L02BG Aromatase inhibitors

506

0.66

1.63

1.4

1.2

0.44

0.58

g/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.62

1.62

1.4

1.1

—

g/l

—

Tonsillectomy and adenotomy

136

764

1.24

1.61

1.1

1.2

0.08

0.28

g/l

—

Chronic diseases of tonsils and adenoids

181

948

1.20

1.61

1.1

1.3

0.17

0.49

g/l

—

Injuries to the wrist and hand

242

1368

1.17

1.61

1.2

0.08

0.53

g/l

3.07

Synovial cyst of popliteal space [Baker]

2.00

1.59

1.0

1.2

—

0.12

g/l

—

Diabetes medication

246

1227

1.17

1.58

1.1

1.2

0.12

0.52

g/l

2.52

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

129

1.71

1.56

1.2

1.1

—

0.16

g/l

—

Lateral epicondylitis

160

1.63

1.55

1.0

1.2

—

0.14

g/l

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

184

1.58

1.54

1.1

1.2

—

0.08

g/l

—

Congenital obstruction of the pelviureteric junction

3.37

1.53

1.0

—

Severe visual impairment, monocular

3.36

1.53

1.2

1.1

—

Gastric ulcer

249

1.49

1.51

1.2

—

0.21

g/l

—

Angina pectoris

117

621

1.25

1.51

1.3

1.2

0.11

0.76

g/l

2.07

Childhood asthma (age<16)

137

1.60

1.51

1.1

1.3

—

0.23

g/l

—

Childhood asthma (age<16), excluding more controls

137

1.60

1.51

1.1

1.3

—

0.23

g/l

—

Other orthopaedic follow-up care

1.90

1.49

1.1

1.2

—

0.43

—

Bicipital tendinitis

2.08

1.49

1.0

1.2

—

0.12

g/l

—

Pneumothorax

1.81

1.47

1.0

1.2

—

0.12

—

Hypoglycaemia, other or unspecified

1.81

1.47

1.1

—

0.06

g/l

—

Crohn disease (strict definition, all UC cases excluded)

1.88

1.44

1.1

1.2

—

0.06

—

Stomatitis and related lesions

319

1.41

1.43

1.5

1.2

0.12

0.23

g/l

—

Leiomyoma of uterus

697

0.80

1.42

1.2

0.24

0.46

g/l

—

Insomnia

213

1268

1.17

1.41

1.3

1.2

0.11

0.53

g/l

—

Contact with other sharp object(s)

103

1.75

1.40

1.2

1.1

—

0.06

g/l

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.42

1.39

1.1

—

Bacterial, viral and other infectious agents

134

1.65

1.39

1.3

1.2

—

0.10

g/l

—

Any dementia

448

0.72

1.38

1.3

1.2

1.64

0.22

g/l

—

Exclusions for E4_PCOS_CONSORTIUM

168

880

1.19

1.38

1.2

0.22

0.38

g/l

0.70

Mental and behavioural disorders due to alcohol, excluding acute intoxication

751

1.25

1.37

1.2

0.16

0.47

g/l

—

Procreative management

492

1.29

1.35

1.2

0.08

0.17

g/l

—

Contact with machinery

165

0.48

1.34

1.0

1.2

—

0.14

—

Inflammatory disease of uterus

216

1.48

1.32

1.1

1.2

—

0.34

g/l

—

Solid cancers, including Hilmo

186

923

1.17

1.29

1.2

0.32

0.13

g/l

0.92

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

257

0.58

1.29

1.1

—

0.13

—

Benign neoplasm: Scapula and long bones of upper limb

2.80

1.29

1.0

1.1

—

Myocardial infarction, strict

507

1.26

1.28

1.2

0.08

0.72

g/l

—

Any dementia, excluding more controls

406

0.73

1.27

1.3

1.2

1.64

0.38

g/l

—

Early lumbar disc prolapse, operated

146

1.58

1.25

1.1

—

0.23

g/l

—

Primary coxarthrosis, bilateral

468

1.30

1.22

1.6

1.2

1.26

0.29

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

140

1.57

1.20

1.2

1.1

—

0.18

g/l

—

Other diseases of gallbladder

1.84

1.19

1.2

1.3

—

0.43

g/l

—

Hypercalcemia

1.88

1.18

1.2

1.3

—

0.42

g/l

—

Vulvovaginal ulceration/inflammation in other diseases

117

1.63

1.18

1.1

1.2

—

0.19

g/l

—

Postprocedural disorders of nervous system

117

1.63

1.18

1.0

1.1

—

0.06

g/l

—

Endometriosis ASRM stages 1,2

298

1.38

1.17

1.0

1.2

—

0.26

g/l

—

Other complications of labour and delivery, not elsewhere classified

188

0.56

1.17

1.0

1.2

—

0.14

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

134

876

1.19

1.15

1.1

1.2

0.30

0.38

g/l

—

Other and unspecified tonsillitis

488

1.26

1.13

1.2

0.12

0.17

g/l

—

Other sexually transmitted chlamydial diseases

1.69

1.13

1.4

1.1

—

0.06

—

Pollen allergy

296

1.37

1.13

1.0

1.2

—

0.14

g/l

—

Colon adenocarcinoma, helper endpoint

182

0.55

1.09

1.6

1.2

—

0.21

g/l

—

Otosclerosis

112

1.61

1.08

1.0

1.3

—

0.24

g/l

—

L02BA Anti-estrogens

268

0.63

1.08

1.2

—

0.40

—

Other noninflammatory disorders of vulva and perineum

153

1.51

1.06

1.0

1.2

—

0.37

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

105

1.62

1.06

1.2

1.1

—

0.13

g/l

—

Solid cancers

175

888

1.16

1.05

1.3

1.2

0.33

0.13

g/l

0.90

Diplopia

195

1.44

1.04

1.1

1.2

—

0.21

g/l

—

Sequelae of injuries of lower limb

146

1.51

1.03

1.0

1.2

—

0.10

—

Sequelae of injuries of head

1.74

1.02

1.4

1.2

—

0.04

—

Other disorders of penis

138

1.52

1.02

1.2

—

0.13

—

Noninflammatory disorders of female genital tract

360

1.23

1.01

1.2

0.34

0.51

g/l

—

Glaucoma

118

847

1.18

1.01

1.2

1.85

0.46

g/l

—

Fracture of forearm

122

930

1.18

1.01

1.3

1.2

0.99

0.33

g/l

—

Hypertrophic disorders of skin

1.77

1.00

1.1

—

0.14

—

Benign lipomatous neoplasm of other sites/unspecified

132

0.53

0.98

1.1

1.3

—

0.25

—

Artrosis, including avohilmo

190

911

1.14

0.98

1.3

1.2

0.38

0.31

g/l

—

Other spirochaetal diseases, including avohilmo

604

1.23

0.95

1.2

0.09

0.22

g/l

—

Malignant neoplasm of breast, HER-positive

408

0.77

0.94

1.4

1.2

0.44

0.13

g/l

—

Presence of other devices

358

0.71

0.94

1.0

1.2

—

0.49

—

Other or unspecified ileus, impaction or obstruction

268

1.34

0.93

1.1

—

0.28

g/l

—

Hallux rigidus

183

1.42

0.93

1.1

1.2

—

0.18

g/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.82

0.92

1.0

1.1

—

0.05

g/l

—

Colorectal adenocarcinoma

252

0.67

0.90

1.5

1.2

—

0.12

g/l

—

Mucosal proctocolitis

210

1.38

0.90

1.2

—

0.22

g/l

—

Other spirochaetal diseases

601

1.22

0.88

1.2

0.09

0.22

g/l

—

Congenital malformations of genital organs

155

0.58

0.88

1.2

1.1

—

0.12

g/l

—

Abnormal findings on antenatal screening of mother

130

0.54

0.87

1.1

1.2

—

0.14

—

Endometriosis diagnosis and infertility diagnosis occurring together

169

1.42

0.87

1.0

1.2

—

0.18

g/l

—

Superficial injury of forearm

153

1.44

0.85

1.1

1.2

—

0.23

g/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

409

0.78

0.85

1.4

1.2

0.44

0.13

g/l

—

Suppurative and necrotic conditions of lower respiratory tract

1.63

0.84

1.1

1.2

—

0.06

—

Essential (haemorrhagic) thrombocythaemia

1.76

0.83

1.2

1.3

—

0.07

—

Hydrocele

154

1.43

0.83

1.3

—

0.66

g/l

—

Lyme disease

597

1.21

0.82

1.2

0.09

0.22

g/l

—

Lyme disease, including avohilmo

597

1.21

0.82

1.2

0.09

0.22

g/l

—

Benign neoplasm: Caecum

164

1.40

0.79

1.1

1.3

—

0.22

g/l

—

Spirochaetal infections, other/unspecified, including avohilmo

600

1.20

0.79

1.2

0.09

0.22

g/l

—

Cellulitis of external ear

0.00

0.79

0.0

1.0

—

Single spontaneous delivery

399

0.82

0.78

1.2

1.3

0.09

0.40

g/l

—

Other and unspecified injuries of head

106

1.51

0.78

1.3

1.2

—

0.30

g/l

—

Coxarthrosis, primary

120

866

1.15

0.78

1.4

1.2

0.94

0.52

g/l

—

Diseases of tongue

1.56

0.78

1.0

1.2

—

0.39

g/l

—

Alcohol dependence

438

1.23

0.77

1.2

0.17

0.42

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

125

0.56

0.77

1.3

1.2

—

0.09

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.76

0.0

1.4

—

0.07

—

Use of antiglaucoma preparations and miotics

107

1.50

0.76

1.2

—

0.10

g/l

—

Abscess of anal and rectal regions

132

1.44

0.75

1.1

1.2

—

0.10

—

Thyrotoxicosis with toxic multinodular goitre

1.54

0.75

1.2

1.3

—

0.33

g/l

—

Vitamin deficiency

1.65

0.75

1.1

—

0.11

g/l

—

Vitamin deficiency, wide

1.65

0.75

1.1

—

0.11

g/l

—

Macular hole

1.60

0.75

1.1

1.4

—

0.29

—

Third [oculomotor] nerve palsy

2.09

0.74

1.0

1.1

—

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

141

1.42

0.74

1.1

1.3

—

0.21

g/l

—

Conductive and sensorineural hearing loss

164

969

1.12

0.74

1.2

1.04

0.47

g/l

—

Other menopausal disorders

284

1.22

0.73

1.1

1.2

0.22

0.54

g/l

—

Malignant neoplasm of small intestine, including Hilmo

1.85

0.73

1.0

1.3

—

0.07

—

Bitten or struck by other mammals

202

1.34

0.72

1.1

1.2

—

0.26

g/l

—

Gluteal tendinitis

1.58

0.71

1.0

1.2

—

0.21

g/l

—

Sensorineural hearing loss

154

914

1.12

0.70

1.2

1.04

0.47

g/l

—

Other (not insulin) diabetes medications

218

1160

1.10

0.70

1.1

1.2

0.13

0.55

g/l

2.40

Adenocarcinoma and papilloma adenocarcinoma of rectum

118

0.59

0.67

1.3

1.2

—

0.06

—

Delivery

402

0.84

0.67

1.2

1.3

0.07

0.40

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

119

1.43

0.66

1.2

1.1

—

0.13

g/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.79

0.66

1.0

1.2

—

0.07

—

Other sexually transmitted chlamydial diseases, including avohilmo

145

1.38

0.65

1.4

1.1

—

0.06

—

Congenital malformations of great arteries

1.76

0.65

1.0

—

Paralytic strabismus

1.48

0.64

1.0

1.3

—

0.30

g/l

—

Persons encountering health services in circumstances related to reproduction

124

737

1.13

0.63

1.3

1.2

0.63

0.17

g/l

0.46

Infections of genitourinary tract in pregnancy

164

1.34

0.62

1.1

1.2

—

0.32

—

Pyothorax

1.59

0.61

1.1

1.3

—

0.06

—

Tongue abnormality

1.46

0.61

1.0

1.3

—

0.27

g/l

—

Contact with venomous snakes and lizards

0.00

0.60

0.0

1.1

—

Tularaemia

0.00

0.59

0.0

1.0

—

Colon adenocarcinoma

151

0.66

0.59

1.6

1.2

—

0.10

g/l

—

Other and unspecified hydrocephalus

0.00

0.59

0.0

1.0

—

Nasal polyp

299

1.24

0.59

1.1

1.2

—

0.24

g/l

—

Excessive attrition of teeth

135

1201

1.11

0.58

1.1

1.2

0.27

0.50

g/l

—

Unspecified lump in breast

255

1.26

0.58

1.0

1.2

—

0.28

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

1.46

0.56

1.1

1.3

—

0.06

—

Hypertrophy of breast in women and men

341

0.79

0.55

1.0

1.2

—

0.19

g/l

—

Hypertrophy of breast

296

0.78

0.55

1.0

1.2

—

0.22

g/l

—

Insulin, fast-acting (human)

239

1.26

0.55

1.4

1.2

0.08

0.12

g/l

—

Burns and corrosions of external body surface, specified by site

171

0.70

0.54

1.0

1.2

—

0.10

g/l

—

Other and unspecified abdominal hernia

1.48

0.53

1.0

1.2

—

0.11

g/l

—

Herpesviral keratitis and keratoconjunctivitis

1.48

0.53

1.1

1.2

—

0.12

g/l

—

Colorectal cancer

314

0.79

0.53

1.3

1.1

—

0.14

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

1.43

0.53

1.1

1.4

—

0.27

g/l

—

Diseases of inner ear

110

943

1.12

0.52

1.1

1.2

0.19

0.51

g/l

—

Hydronephrosis

143

1.33

0.52

1.1

—

0.14

—

Other and unspecified vascular occlusions

117

1.37

0.52

1.1

1.3

—

0.22

g/l

—

Diseases of middle ear and mastoid

126

930

1.11

0.51

1.3

1.2

0.22

0.28

g/l

—

Carcinoma in situ of other and unspecified digestive organs

1.39

0.50

1.2

1.3

—

0.07

—

Colorectal cancer, including Hilmo

344

0.81

0.50

1.3

1.1

—

0.14

g/l

—

Coxarthrosis, primary, with hip surgery

741

1.13

0.50

1.4

1.2

0.94

0.57

g/l

—

Complications of labour and delivery

109

674

0.90

0.49

1.2

1.28

0.38

g/l

—

Other diseases of biliary tract

136

1.32

0.49

1.2

—

0.32

g/l

—

Fall on and from ladder

110

1.37

0.48

1.0

1.2

—

0.10

g/l

—

Benign neoplasm: Choroid

102

1.37

0.47

1.1

1.3

—

0.25

—

Spontaneous rupture of synovium and tendon

1.41

0.46

1.0

1.2

—

0.12

g/l

—

Special screening examination for other diseases and disorders

164

1.28

0.46

1.0

1.1

—

0.20

g/l

—

Biomechanical lesions, not elsewhere classified

1.43

0.45

1.0

1.2

—

0.12

—

Oesophageal obstruction

1.40

0.45

1.1

1.3

—

0.07

—

Other noninflammatory disorders of uterus, except cervix

243

1.18

0.44

1.7

1.2

0.49

0.61

g/l

—

Malignant neoplasm of breast

463

0.88

0.44

1.3

1.2

0.43

0.12

g/l

—

Malignant neoplasm of breast, HER2-negative

462

0.88

0.43

1.3

1.2

0.43

0.12

g/l

—

Malignant neoplasm of colon, including Hilmo

229

0.78

0.43

1.3

1.2

—

0.13

g/l

—

Other osteochondropathies

104

1.35

0.43

1.1

1.2

—

0.07

g/l

—

Contraceptive management

543

0.89

0.42

1.3

1.2

1.31

0.16

g/l

—

Other congenital malformations of intestine, including avohilmo

0.00

0.41

0.0

1.1

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.41

0.0

1.0

—

Short stature, not elsewhere classified

0.00

0.41

0.0

1.1

—

Struck by thrown, projected or falling objec

1.39

0.40

1.0

1.2

—

0.06

—

Biguanides

205

1157

1.07

0.40

1.1

1.2

0.14

0.49

g/l

—

Other disorders of cornea

159

1.26

0.40

1.0

1.2

—

0.14

g/l

—

Mixed specific developmental disorders

0.00

0.40

0.0

1.1

—

Hydrocephalus

104

0.67

0.39

1.0

1.4

—

0.25

—

Abnormalities of forces of labour

171

0.76

0.39

1.2

—

0.15

g/l

—

Postpartum haemorrhage due to retained placenta

182

0.77

0.39

1.2

1.3

—

0.23

—

Heartburn

160

1.25

0.38

1.2

—

0.31

—

Bronchitis, not specified as acute or chronic

113

0.71

0.37

1.3

1.2

—

0.24

g/l

—

Contusion of other and unspecified parts of foot

1.36

0.36

1.1

—

0.06

—

Focal brain injury

1.27

0.36

1.1

—

0.06

—

Other abnormal products of conception

387

1.12

0.36

1.0

1.2

—

0.33

g/l

—

Muscle strain

1.40

0.35

1.2

—

0.11

—

Mixed conductive and sensorineural hearing loss

172

1.22

0.34

1.2

1.1

—

0.16

—

Parkinson's disease, excluding more controls

150

1.23

0.33

1.1

—

0.06

g/l

—

Antepartum haemorrhage, not elsewhere classified

144

0.76

0.33

1.3

1.1

—

0.10

—

Ptosis of eyelid

155

1.23

0.32

1.1

1.2

—

0.27

—

Otitis externa, unspecified

201

1.19

0.32

1.0

1.2

—

0.24

g/l

—

Additional codes for the location of defect, injury or illness

1.31

0.31

1.2

—

0.10

—

Foreign body on external eye

241

0.83

0.31

1.1

1.2

—

0.13

g/l

—

Pre-eclampsia or poor fetal growth

539

1.11

0.31

1.5

1.2

1.31

0.30

g/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.73

0.31

1.3

1.1

—

0.09

g/l

—

Clear cell adenocarcinoma of kidney

1.32

0.30

1.0

1.3

—

0.06

—

Hypermetropia

0.71

0.30

1.0

1.2

—

0.13

—

Ulcerative rectosigmoiditis

138

1.23

0.30

1.1

1.2

—

0.12

g/l

—

Vestibular neuronitis

138

1.23

0.30

1.1

1.3

—

0.24

—

Burns and corrosions

218

0.83

0.30

1.0

1.2

—

0.21

g/l

—

Vasomotor rhinitis (mode)

111

1.26

0.30

1.4

1.3

—

0.24

g/l

—

Fitting and adjustment of other devices

503

1.10

0.29

1.0

1.2

—

0.44

g/l

—

Crowding of teeth, including avohilmo

108

0.77

0.29

1.5

1.2

—

0.06

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

107

0.75

0.29

1.4

1.2

—

0.10

g/l

—

Pregnancy hypertension

666

1.09

0.28

1.3

1.2

1.31

0.42

g/l

—

Inguinal or femoral hernia, bilateral

162

0.80

0.28

1.0

1.2

—

0.10

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

1.28

0.28

1.3

—

0.37

—

Vascular syndromes of brain in cerebrovascular disorders

1.29

0.28

1.0

1.3

—

0.05

—

Retained placenta and membranes, without haemorrhage

186

1.18

0.27

1.2

—

0.31

g/l

—

Other vitreous opacities

1.25

0.27

1.1

1.2

—

0.12

g/l

—

Other obstructed labour

119

0.76

0.27

1.1

1.2

—

0.21

—

Ulcerative proctitis

104

1.25

0.26

1.2

1.1

—

0.07

g/l

—

Other diseases of stomach and duodenum

1.26

0.26

1.2

1.3

—

0.26

g/l

—

Caught, crushed, jammed or pinched in or between objects

1.28

0.26

1.2

—

0.05

g/l

—

Unspecified abortion

1.30

0.26

1.0

1.2

—

0.15

g/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.30

0.26

1.1

1.2

—

0.06

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

123

1.22

0.25

1.1

1.2

—

0.10

g/l

—

Inguinal hernia, bilateral

159

0.82

0.24

1.0

1.2

—

0.09

g/l

—

Hyperplasia of prostate

298

1.10

0.24

1.2

1.3

0.23

0.74

g/l

—

Tobacco use

1.27

0.24

1.2

—

0.07

g/l

—

Glaucoma-related operations

0.71

0.24

1.2

1.4

—

0.29

g/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

293

1.13

0.24

1.2

—

0.21

g/l

—

Malignant neoplasm of breast, including Hilmo

469

0.93

0.21

1.3

1.2

0.43

0.12

g/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

469

0.93

0.21

1.3

1.2

0.43

0.12

g/l

—

Delayed milestone in childhood

0.00

0.21

0.0

1.1

—

Other and unspecified cicatricial alopecia

0.00

0.21

0.0

1.1

—

Complications of anaesthesia during labour and delivery

0.00

0.21

0.0

1.0

—

Acute thyroiditis

0.00

0.21

0.0

1.0

—

Complications specific to multiple gestation

0.00

0.21

0.0

1.0

—

Typhoid and paratyphoid fevers

0.00

0.21

0.0

1.1

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.1

—

Other disorders of prostate

1.19

0.21

1.4

1.3

—

0.06

—

Benign neoplasm: Brain, infratentorial

0.00

0.21

0.0

1.0

—

Other adrenocortical overactivity

0.00

0.21

0.0

1.1

—

Common variable immunodeficiency

0.00

0.21

0.0

1.1

—

Benign neoplasm: Orbit, unspecified

0.00

0.21

0.0

1.0

—

Osteochondrosis of ankle, juvenile

0.00

0.21

0.0

1.0

—

Other specified transport accidents

0.00

0.21

0.0

1.1

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.1

—

Other superficial injuries of ankle and foot

0.00

0.21

0.0

1.1

—

Degenerative myopia

0.00

0.21

0.0

1.1

—

Other and unspecified primary disorders of muscles

0.00

0.21

0.0

1.1

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

Osteitis due to dental implant

0.00

0.21

0.0

1.1

—

Cholesteatoma of external ear

0.00

0.21

0.0

1.1

—

Other congenital malformations of intestine

0.00

0.21

0.0

1.0

—

Other and unspecified injuries of neck

0.00

0.21

0.0

1.0

—

Other and unspecified disorders of autonomic nervous system

0.00

0.21

0.0

1.0

—

Sequelae of poliomyelitis, including avohilmo

0.00

0.21

0.0

1.1

—

Malignant neoplasm of colon

188

0.85

0.21

1.4

1.2

—

0.15

g/l

—

Other and unspecified disorders of psychological development

0.00

0.21

0.0

1.0

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

Increased muscle tone

0.00

0.21

0.0

1.1

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.0

—

Endometriosis of fallopian tube

0.00

0.21

0.0

1.1

—

Effects of heat and light

0.00

0.21

0.0

1.1

—

Delivery, wide proxy

322

0.92

0.20

1.2

1.3

0.55

0.36

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases

1.25

0.20

1.0

1.1

—

0.05

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

1.25

0.20

1.0

1.1

—

0.05

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.20

0.0

1.1

—

Respiratory tuberculosis, clinically confirmed

0.00

0.20

0.0

1.1

—

0.00

0.20

0.0

1.1

—

Isolated patent ductus arteriosus

0.00

0.20

0.0

1.0

—

Embedded teeth, including avohilmo

136

1.18

0.20

1.1

—

0.06

—

Vascular dementia

109

0.80

0.20

1.1

1.3

—

0.38

g/l

—

Familial hypercholesterolemia, with ischemic heart disease

114

0.79

0.20

1.2

—

0.68

—

Parkinson's disease, including avohilmo

229

0.87

0.20

1.1

1.2

—

0.22

g/l

—

Malignant neoplasm of rectum, including Hilmo

144

0.83

0.19

1.2

—

0.09

—

Carcinoma in situ of cervix uteri

174

1.15

0.19

1.1

1.2

—

0.12

g/l

—

Parkinson's disease, strict definition

197

0.86

0.19

1.1

1.2

—

0.21

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

231

1.13

0.19

1.1

1.2

—

0.29

g/l

—

Other peripheral vertigo

137

1.17

0.18

1.2

1.3

—

0.24

g/l

—

Complications following abortion and ectopic and molar pregnancy

1.13

0.18

1.0

1.4

—

0.44

g/l

—

Other contact dermatitis

100

1.20

0.18

1.2

1.1

—

0.15

—

Parkinson's disease, strict definition, excluding more controls

137

1.16

0.18

1.1

—

0.06

g/l

—

Malignant neoplasm of rectum

121

0.83

0.18

1.3

1.2

—

0.06

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

237

0.89

0.17

1.2

—

0.22

g/l

—

Respiratory tuberculosis, confirmed and not-confirmed

1.15

0.17

1.1

1.3

—

0.07

g/l

—

Respiratory tuberculosis

1.15

0.17

1.1

1.3

—

0.07

g/l

—

Complications of the puerperium, not elsewhere classified

0.73

0.17

1.0

1.1

—

0.09

—

Coronary artery bypass grafting

266

1.09

0.16

1.2

1.3

0.10

1.24

g/l

—

Organic, including symptomatic, mental disorders

650

1.05

0.16

1.2

1.25

0.35

g/l

—

Contact with heat and hot substances

0.75

0.15

1.0

1.2

—

0.06

g/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.14

0.15

1.2

—

0.06

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

735

1.05

0.15

1.3

1.2

1.31

0.41

g/l

—

Lesion of plantar nerve

1.11

0.15

1.4

1.3

—

0.31

g/l

—

Impacted maxillary molar

1.18

0.14

1.0

1.2

—

0.06

—

Ethmoidectomy

217

1.11

0.14

1.1

1.2

—

0.23

g/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

553

0.94

0.14

1.2

0.09

0.37

g/l

—

Glucagon-like peptide-1 (GLP-1) analogues

553

0.94

0.14

1.2

0.09

0.37

g/l

—

Periapical abscess

861

1.05

0.14

1.1

1.2

0.21

0.36

g/l

—

Medical abortion

125

651

1.04

0.14

1.2

0.40

0.45

g/l

—

Divergent concomitant strabismus

113

1.15

0.13

1.2

—

0.11

—

Pneumonitis due to solids and liquids

113

1.15

0.13

1.0

1.2

—

0.11

—

Conductive hearing loss, unspecified

123

1.14

0.12

1.1

1.2

—

0.16

g/l

—

Lichen sclerosus et atrophicus

123

1.14

0.12

1.1

—

0.12

g/l

—

Anogenital herpesviral [herpes simplex] infection

104

1.15

0.12

1.2

1.1

—

0.07

g/l

—

Multiple delivery

153

1.11

0.11

1.1

1.2

—

0.34

—

Sequelae of infectious and parasitic diseases

105

1.14

0.11

1.0

1.1

—

0.10

—

Pregnancy, childbirth and the puerperium

270

0.95

0.11

1.2

1.3

0.55

0.39

g/l

—

False labour

333

0.95

0.10

1.2

1.1

—

0.18

g/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

270

1.07

0.10

1.2

—

0.21

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.15

0.10

1.1

1.2

—

0.10

g/l

—

Foreign body entering into or through eye or natural orifice

125

0.88

0.10

1.1

1.2

—

0.07

g/l

—

Presbyopia

125

0.88

0.10

1.1

1.2

—

0.17

g/l

—

Acute gastritis

106

1.13

0.09

1.0

1.3

—

0.23

—

Parkinson's disease

217

0.92

0.09

1.1

1.2

—

0.23

g/l

—

Other infective otitis externa

1.13

0.09

1.0

1.2

—

0.06

—

Malignant neoplasm, without specification of site, including Hilmo

1.09

0.08

1.0

1.3

—

0.05

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1.07

0.08

1.2

1.3

—

0.06

g/l

—

Polypectomy (DHB20)

107

1.12

0.08

1.2

—

0.07

g/l

—

Benign neoplasm: Skin of trunk

0.82

0.08

1.0

1.2

—

0.12

g/l

—

Malignant neoplasm of stomach

0.79

0.08

1.2

1.3

—

0.07

g/l

—

Use of selegiline

0.78

0.08

1.0

1.4

—

0.29

—

Normal-pressure hydrocephalus

0.78

0.08

1.0

1.3

—

0.12

—

Follicular lymphoma, hilmo

1.04

0.08

1.0

1.4

—

0.37

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

127

1.10

0.08

1.1

1.3

—

0.26

g/l

—

Type1 diabetes, definitions combined, early onset

1.13

0.07

1.1

1.2

—

0.06

g/l

—

Impacted cerumen

176

1.08

0.07

1.1

1.3

—

0.24

g/l

—

Malignant neoplasm of pancreas

0.84

0.07

1.4

1.3

—

0.06

—

Perforation of tympanic membrane

153

0.91

0.07

1.1

1.2

—

0.23

g/l

—

Right hemicolectomy

0.82

0.07

1.1

1.3

—

0.11

g/l

—

FESS (DNB20)

206

1.07

0.07

1.1

1.2

—

0.23

g/l

—

Pleural plaque with presence of asbestos

0.87

0.06

1.0

1.2

—

0.07

—

Chronic suppurative otitis media

0.86

0.06

1.0

1.2

—

0.10

—

Malignant neoplasm of head and neck

102

0.88

0.06

1.0

1.2

—

0.06

—

Spermatocele

105

0.86

0.06

1.0

1.2

—

0.13

—

Other disorders of amniotic fluid and membranes

235

0.94

0.06

1.2

—

0.16

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

178

1.07

0.05

1.1

1.2

—

0.20

—

Tuberculosis, IBD comorbidity

1.11

0.05

1.2

1.3

—

0.30

g/l

—

Ulcerative colitis (strict definition, require KELA)

277

1.05

0.05

1.2

—

0.21

g/l

—

Pleural plaque

110

0.91

0.05

1.0

1.2

—

0.15

—

Single delivery by forceps and vacuum extractor

175

0.95

0.05

1.1

1.2

—

0.08

—

Sequelae of infectious and parasitic diseases, including avohilmo

110

1.09

0.05

1.0

1.2

—

0.10

—

Type 1 diabetes, strict definition

119

0.92

0.04

1.1

—

0.09

g/l

—

Chronic suppurative otitis media, including avohilmo

109

0.92

0.04

1.0

1.3

—

0.10

—

Crushed, pushed or stepped on by crowd or human stampede

111

1.08

0.04

1.2

1.1

—

0.05

g/l

—

Malignant neoplasm of head and neck, including Hilmo

121

1.07

0.03

1.0

1.2

—

0.06

—

Inguinal hernia

108

707

1.01

0.03

1.2

0.07

0.46

g/l

—

Female infertility, cervical, vaginal, other or unspecified origin

288

1.02

0.02

1.0

1.2

—

0.44

g/l

—

Tuberculosis, wide

1.08

0.02

1.2

1.4

—

0.27

g/l

—

Other appendicitis

133

1.05

0.01

1.1

1.2

—

0.12

g/l

—

Artificial joint re-operation

104

1.06

0.01

1.0

1.3

—

0.24

—

LSIL lesion of the cervix uteri

184

1.03

0.00

1.2

—

0.18

g/l

—

Other blood glucose lowering drugs, excl. Insulins

246

1.02

0.00

1.1

1.2

—

0.40

g/l

—

Tuberculosis, wide, including avohilmo

1.05

0.00

1.2

1.4

—

0.27

g/l

—

Lichen planus

185

0.97

0.00

1.2

—

0.27

g/l

—

Pregnancy examination and test

174

1.00

0.00

1.1

—

0.08

g/l

—

Effects of foreign body entering through natural orifice

419

1.00

0.00

1.1

1.2

—

0.20

g/l

—

Childhood allergy (age < 16)

166

0.99

0.00

1.1

1.2

—

0.08

g/l

—

Normotensive glaucoma

126

1.03

0.00

1.1

1.2

—

0.10

g/l

—

Persistent delusional disorders

113

0.97

0.00

1.1

1.3

—

0.30

—

Type 1 diabetes, strict definition, subgroup 1

113

0.97

0.00

1.1

—

0.09

g/l

—

Congenital lens malformations

0.00

0.0

1.0

—

Precocious puberty

0.00

0.0

1.0

—

Tuberculosis

1.01

0.00

1.1

1.3

—

0.11

g/l

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.0

—

Injury of nerves at hip and thigh level

0.00

0.0

1.2

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.0

—

Brain astrocytoma, helper endpoint

0.00

0.0

1.0

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.0

—

Other leukaemias of specified cell type

0.00

0.0

1.0

—

Unspecified multiple injuries

0.00

0.0

1.0

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.0

1.0

—

Varicose veins of other sites

0.98

0.00

1.0

1.3

—

0.26

—

Diphtheria, including avohilmo

0.00

0.0

1.0

—

Exposure to uncontrolled fire in building or structure

0.00

0.0

1.0

—

Constitutional tall stature

0.00

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.1

—

Carcinoid syndrome

0.00

0.0

1.1

—

Radiodermatitis

0.00

0.0

1.2

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.88

0.00

1.2

1.3

—

0.43

—

Frontotemporal dementia

0.00

0.0

1.1

—

Benign neoplasm: Vertebral column

0.00

0.0

1.0

—

Unicornuate uterus

0.00

0.0

1.0

—

Idiopathic hypoparathyroidism

0.00

0.0

1.2

—

Other and unspecified heterotropia

0.00

0.0

1.0

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.0

1.1

—

Diseases of thymus

0.00

0.0

1.0

—

Pectus excavatum

0.00

0.0

1.0

—

Reduction defects of upper limb, including avohilmo

0.00

0.0

1.0

—

Reduction defects of upper limb

0.00

0.0

1.0

—

Acne conglobata

0.00

0.0

1.0

—

Congenital hydrocephalus

0.00

0.0

1.0

—

Nezelof syndrome

0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.95

0.00

1.6

1.4

—

0.27

—

Perforation of oesophagus

0.00

-0.00

0.0

1.2

—

Effects of other deprivation

0.00

-0.00

0.0

1.0

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

1.0

—

Toxic effect of corrosive substances

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified effects of external causes

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.0

—

Unattended death

0.00

-0.00

0.0

1.0

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

1.0

—

Upper arm

0.00

-0.00

0.0

1.0

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.0

—

Other secondary coxarthrosis

0.94

-0.00

1.6

1.2

—

0.12

g/l

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.2

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

1.0

—

Syndactyly

0.00

-0.00

0.0

1.0

—

Reduction defects of lower limb

0.00

-0.00

0.0

1.0

—

Anuria and oliguria

0.00

-0.00

0.0

1.0

—

Spina bifida

0.00

-0.00

0.0

1.0

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.0

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.0

—

Congenital cataract

0.00

-0.00

0.0

1.0

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

Other congenital malformations of brain

0.00

-0.00

0.0

1.0

—

Reduction defects of lower limb, including avohilmo

0.00

-0.00

0.0

1.0

—

Cleft lip

0.00

-0.00

0.0

1.0

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.0

—

Syndactyly, including avohilmo

0.00

-0.00

0.0

1.0

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

190

1.00

-0.00

1.1

1.3

—

0.21

g/l

—

Slow fetal growth and fetal malnutrition

0.00

-0.00

0.0

1.0

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

-0.00

0.0

1.1

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.0

—

Toxic effect of other gases, fumes and vapours

0.00

-0.00

0.0

1.0

—

Exposure to ignition of highly flammable material

0.00

-0.00

0.0

1.2

—

Infections specific to the perinatal period

0.00

-0.00

0.0

1.0

—

Feeding problems of newborn

0.00

-0.00

0.0

1.0

—

Foreign body or object entering through skin

0.94

-0.00

1.0

1.2

—

0.07

g/l

—

Complications of anaesthesia during pregnancy

0.00

-0.00

0.0

1.0

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.96

-0.00

1.0

1.1

—

0.05

—

Explosion of other materials

0.00

-0.00

0.0

1.0

—

Fall involving playground equipment

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.92

-0.00

1.1

—

0.23

g/l

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.0

—

Degenerative macular diseases, drug-induced

0.00

-0.00

0.0

1.2

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.0

—

Muscle wasting and atrophy, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

100

1.00

-0.00

1.3

1.2

—

0.06

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.2

—

Car occupant injured in noncollision transport accident

0.88

-0.00

1.0

1.1

—

0.04

—

Malignant neoplasm of stomach, including Hilmo

0.91

-0.00

1.2

1.3

—

0.06

g/l

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Hypertrophy of bone

0.00

-0.00

0.0

1.0

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.0

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

1.2

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.0

—

Convalescence

0.90

-0.00

1.1

1.2

—

0.37

g/l

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

1.2

—

Lichen planopilaris

0.00

-0.00

0.0

1.0

—

Excessive and redundant skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.0

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

-0.00

0.0

1.0

—

Other ulcerative colitis

0.99

-0.00

1.1

1.2

—

0.06

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

1.2

—

Female infertility, uterine origin

0.00

-0.00

0.0

1.0

—

Severe visual impairment, binocular

0.00

-0.00

0.0

1.1

—

Labyrinthine fistula

0.00

-0.00

0.0

1.0

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.0

—

Other congenital malformations of urinary system

0.00

-0.00

0.0

1.2

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

1.0

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.0

—

Toxic effect of organic solvents

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

-0.00

0.0

1.0

—

Other endophthalmitis

0.00

-0.00

0.0

1.1

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

-0.00

0.0

1.0

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.0

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

-0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.93

-0.00

1.2

1.1

—

0.17

g/l

—

Hereditary factor VIII deficiency

0.00

-0.00

0.0

1.0

—

Ovarian dysfunction: androgen excess

0.00

-0.00

0.0

1.0

—

Thiamine deficiency

0.00

-0.00

0.0

1.0

—

Calculus of lower urinary tract

0.91

-0.00

1.0

1.2

—

0.07

—

Atrioventricular septal defect

0.00

-0.00

0.0

1.0

—

Impotence

1.01

-0.00

1.3

1.2

—

0.07

—

Isolated growth hormone deficiency

0.00

-0.00

0.0

1.0

—

Nondiabetic hypoglycaemic coma

0.00

-0.00

0.0

1.2

—

Hereditary corneal dystrophies

0.91

-0.00

1.0

1.2

—

0.12

—

Thalassaemia

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Brain, unspecified

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.0

—

Follicular adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Rhinophyma

0.00

-0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.94

-0.00

1.0

1.2

—

0.10

g/l

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

-0.00

0.0

1.0

—

Seminoma of testis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of oral cavity, including Hilmo

0.92

-0.00

1.0

1.2

—

0.07

—

Other and unspecified myoneural disorders

0.00

-0.00

0.0

1.1

—

Neuroendocrine tumor and carcinoma of pancreas

0.00

-0.00

0.0

1.0

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.0

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.0

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.0

—

Pectus excavatum, including avohilmo

0.00

-0.00

0.0

1.0

—

Urethral stricture

0.99

-0.00

1.0

1.2

—

0.08

g/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

-0.00

0.0

1.1

—

Epileptic seizures related to alcohol

0.00

-0.00

0.0

1.0

—

Contact urticaria

0.00

-0.00

0.0

1.0

—

Adenocarcinomas of cervix

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

-0.00

0.0

1.0

—

Other disorders of carbohydrate metabolism

0.00

-0.00

0.0

1.0

—

Use of entacapone

0.00

-0.00

0.0

1.1

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.2

—

Other or unspecified common variable immunodeficiency

0.00

-0.00

0.0

1.0

—

Enduring personality changes

0.00

-0.00

0.0

1.0

—

Other operation for atrial fibrillation

0.00

-0.00

0.0

1.0

—

Surgical ablation of atrial fibrillation

0.00

-0.00

0.0

1.0

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

-0.00

0.0

1.0

—

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

1.0

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.0

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.0

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.2

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

-0.00

0.0

1.0

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.1

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.96

-0.00

1.0

1.2

—

0.11

—

Other cestode infections

0.00

-0.00

0.0

1.1

—

Disorders of male genital organs in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cryoglobulin [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS